Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cancer of Pancreas

fluorodeoxyglucose f18 has been researched along with Cancer of Pancreas in 552 studies

Research

Studies (552)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	36 (6.52)	18.2507
2000's	132 (23.91)	29.6817
2010's	284 (51.45)	24.3611
2020's	100 (18.12)	2.80

Authors

Authors	Studies
Akazawa, Y; Hiramatsu, K; Matsuda, H; Naito, T; Nakamoto, Y; Nosaka, T; Ofuji, K; Ohtani, M; Ozaki, Y; Saito, Y; Takahashi, K	1
Bagni, O; Filippi, L; Potenza, C; Proietti, I; Schillaci, O	1
Gantumur, D; Kamioka, H; Li, Y; Mizoi, K; Ogihara, T; Tsushima, Y; Zhang, X; Zhu, M	1
Griffin, L; Kawalilak, L; Walczak, R	1
Gong, W; Ou, L; Wu, J; Yang, X; Zhang, C	1
Adinehpour, Z; Aghdam, RA; Haghighi, S; Kaghazchi, F; Vali, R	1
Li, H; Li, Q; Wu, Y; Xiang, X; Zhou, J	1
Erdur, E; Guzel, Y; Kaplan, H; Poyraz, K; Yildirim, MS; Yildirim, OA	1
Gai, Y; Kang, R; Li, H; Li, J; Li, Z; Muschler, J; Sun, L; Tang, D; Zeng, D	1
Ando, Y; Kamada, H; Masaki, T; Matsukawa, H; Okano, K; Oshima, M; Shibata, T; Suto, H; Suzuki, Y; Takahashi, S	1
Baba, S; Ishigami, K; Isoda, T; Kitamura, Y; Nakata, K; Nishie, A; Oda, Y; Shimomura, Y; Tabata, K; Yamada, Y	1
Arakawa, S; Asano, Y; Hayashi, C; Higashiguchi, T; Horiguchi, A; Ito, M; Kamio, K; Kato, H; Kawabe, N; Kawai, T; Koike, D; Kondo, Y; Nagata, H; Shimura, M	1
Berti, S; El Khouzai, B; Gregianin, M; Guglielmo, P; Muccioli, S; Pesella, F; Sartorello, A	1
Jeong, SY; Kim, SJ; Lee, SW; Shim, SR	1
Adinehpour, Z; Akbarian Aghdam, R; Amini, H; Divband, G; Kaghazchi, F	1
Agrawal, K; Gnanasegaran, G; Wan, S	1
Kabel, AM; Magdy, AA; Mokhtar, HM; Naguib, TM; Sabry, NM; Salama, SA; Youssef, A	1
Liu, X; Lu, L; Ren, Y; Wang, J; Yang, X	1
Dai, M; Jing, F; Liu, Y; Tian, W; Wang, J; Wang, N; Wang, T; Zhang, J; Zhang, Z; Zhao, X	1
Abdelrahman, AM; Alva-Ruiz, R; Cleary, SP; Goenka, AH; Graham, RP; Grotz, TE; Haddock, MG; Halfdanarson, TR; Hallemeier, CL; Kendrick, ML; Leiting, JL; Ma, WW; McWilliams, RR; Merrell, KW; Nagorney, DM; Smoot, RL; Thiels, CA; Tran, NH; Truty, MJ; Warner, SG; Yonkus, JA	1
Barrs, C; Bhosale, P; Francis, IR; Iravani, A; Itani, M; Mhlanga, J; Morani, A; Yano, M; Zulfiqar, M	1
Bang, S; Han, K; Hwang, HK; Hwang, SH; Kim, MJ; Kim, SS; Lee, HS; Park, MS; Yoon, JK; Yun, M	1
Buck, AK; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Schlötelburg, W; Serfling, SE; Weich, A; Werner, RA	1
Huang, Z; Lin, J; Liu, Z; Wang, R; Wu, M	1
Larcos, G; Power, J	1
Abe, T; Baba, S; Fujimori, N; Fujita, N; Hayashi, M; Ideno, N; Ikenaga, N; Ishigami, K; Isoda, T; Murakami, M; Nakamura, M; Nakamura, S; Nakata, K; Oda, Y	1
Henderson, A; Khatri, W; Rowe, SP; Solnes, LB; Spiro, E	1
Fujii, H; Fujiwara, Y; Ishido, N; Kadowaki, Y; Komoto, S; Kubota, T; Matano, T; Okino, T; Okubo, Y; Shirasaka, D; Watanabe, A	1
de Groot, JB; de Jong, TL; Jager, PL; Koopman, D; Lioe-Fee, GO; Meijssen, MAC; Mieog, JSD; Nieuwenhuijs, VB; Patijn, GA; Stevens, H; Vahrmeijer, AL; van der Worp, CAJ; Vuijk, FA	1
Agrawal, K; Bishnoi, K; Kumar, P; Parida, GK; Singh, P; Singhal, T	1
Al Darazi, M; Al Mahmasani, L; Charafeddine, M; Chehade, L; El Jebai, M; Elias, C; Haidar, M; Shamseddine, A; Temraz, S	1
Chen, H; Lin, Q; Pang, Y; Sun, L; Wu, H; Zhao, L	1
Evangelista, L; Filippi, L; Frantellizzi, V; Schillaci, O	1
Chen, L; Li, J; Xiao, Y; Xie, R; Yang, C; Zha, Y	1
Duncan, ZN; Galgano, SJ; Morgan, DE; Packard, AT; Summerlin, D; West, JT	1
Jang, JY; Joo, I; Lee, DH; Lee, JM; Lee, SH; Yoo, J; Yoon, JH; Yu, MH	1
Abe, K; Cardinale, J; Doki, Y; Eguchi, H; Giesel, FL; Inohara, H; Kamiya, T; Kato, H; Kimura, T; Kobayashi, S; Kurokawa, Y; Miyake, T; Mori, Y; Naka, S; Shimazu, K; Shintani, Y; Tatsumi, M; Watabe, T	1
Cheng, C; Guo, S; Zhang, Z; Zuo, C	1
He, M; Jiang, L; Qiu, T; Ren, J; Tan, X; Zhang, Q	1
Fukukura, Y; Hasegawa, K; Kageyama, S; Kameda, A; Marugami, N; Nakai, Y; Nakano, T; Nakaya, M; Sato, K; Sofue, K; Takahashi, M; Takeyama, N; Tanaka, M; Tashiro, Y; Watadani, T; Yoshimitsu, K	1
Ahn, E; Feng, D; Gu, B; Huang, Q; Jiang, C; Kim, J; Song, S; Yuan, Y	1
Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ	1
Chen, Y; Lin, Y; Miao, W; Wu, Z; Zheng, S	1
Bai, Y; Gao, J; Huang, X; Li, B; Lin, X; Miao, F; Rominger, A; Schwaiger, M; Shi, K; Zhu, H	1
Chen, S; Lin, Z; Miao, W; Wang, C	1
Colbatzky, T; Giesel, FL; Glatting, FM; Gutjahr, E; Haberkorn, U; Hackert, T; Heger, U; Hielscher, T; Hoppner, J; Kratochwil, C; Lang, M; Liermann, J; Pausch, T; Röhrich, M; Spektor, AM; Sperling, L; van Genabith, L	1
Brennan, T; Chen, H; Goenka, AH; Herrmann, K; Jacobson, M; Karbhari, A; Kuo, PH; Mosessian, S; Patnam, NG; Simeone, DM; Trivedi, KH; Truty, MJ; Valla, F; Zan, E	1
Sauvanet, A; Wartski, M	1
Dong, P; Hou, S; Liu, X; Shen, G; Tian, B; Wang, L; Zhang, Y	1
Endo, Y; Fujinaga, A; Hirashita, T; Inomata, M; Itai, Y; Iwashita, Y; Masuda, T; Nakanuma, H; Ohta, M; Tada, K	1
Jiang, B; Shi, H; Teng, X; Wang, S; Yang, F	1
Cheng, C; Liu, Z; Pan, G; Sun, G; Yang, X; Zhang, Y; Zuo, C	1
Cheng, X; Hou, G; Jiang, Y	1
Baum, RP; Kulkarni, HR; Zhang, J	1
Coriat, R; Palmieri, LJ	1
Baratto, L; Duan, H; Iagaru, A	1
Cheng, X; Hou, G; Jiang, Y; Li, F	1
Chen, Y; Cui, B; Ren, F; Su, W; Wang, M; Zhao, S; Zuo, C	1
Li, F; Luo, Y; Pan, Q; Zhang, W	1
Cho, YS; Choi, JY; Hyun, SH; Lee, JK; Lee, KH; Lim, CH; Min, JH	1
Arena, J; Bailey, EA; Chua, TC; Clarke, SJ; Gill, AJ; Hruby, G; Itchins, M; Jamieson, NB; Kneebone, A; Mittal, A; Nahm, CB; O'Connell, RL; Pavlakis, N; Samra, JS; Schembri, GP	1
Akhurst, T; Hicks, RJ; Jefford, M; Kuru, N; Liauw, W; Link, E; Lung, MS; Michael, M; Pavlakis, N; Thomson, B; Wyld, DK	1
Dong, A; Dong, H; He, Q; Ji, X; Zuo, C	1
Chen, Y; Fu, Z; Ge, B; Li, M; Li, Y; Que, R; Tao, Z	1
Dong, A; Dong, H; Zhou, W	1
Dong, P; Hu, W; Li, M; Liu, X; Tian, B; Wang, L; Wang, W	1
Li, B; Li, T; Liu, MF; Xi, Y; Yuan, P; Zhang, M	1
Adler, SS; Brender, JR; Choudhuri, R; Choyke, PL; Devasahayam, N; Jagoda, EM; Kishimoto, S; Krishna, MC; Mitchell, JB; Oshima, N; Saito, K; Seki, T; Yamamoto, K	1
Abe, Y; Endo, Y; Hori, S; Ishii, R; Iwabuchi, Y; Jinzaki, M; Kitagawa, Y; Kitago, M; Masugi, Y; Matsusaka, Y; Nakahara, T; Okuda, S; Oshima, G; Shinoda, M; Takemura, R; Toyama, K; Yagi, H; Yokose, T	1
Chen, JW; Huang, WS; Xu, JH; Zhang, GX; Zheng, Y	1
Gaujoux, S; Libé, R; Meyer, C; Paepegaey, AC; Rouquette, A	1
Bieg, C; Chirindel, AF; Gass, M; Metzger, J; Mongelli, F; Peterli, R; von Flüe, M	1
Fujiwara, K; Ishida, H; Kanamitsu, K; Shimada, A; Tsukahara, H; Washio, K	1
Groshek, L; He, J; Teinor, J	1
Bignotto, A; Cecchin, D; Evangelista, L; Ravelli, I; Zucchetta, P	1
Abolmaali, N; Baumann, M; Blum, S; Distler, M; Folprecht, G; Grützmann, R; Jentsch, C; Polster, H; Saeger, HD; Troost, EGC; Weitz, J; Zimmermann, C; Zöphel, K	1
Cheng, X; Huo, L; Li, F; Wang, P	1
Andreasi, V; Bettinardi, V; Doraku, J; Falconi, M; Gianolli, L; Mapelli, P; Muffatti, F; Partelli, S; Pasetto, S; Picchio, M; Presotto, L; Rancoita, PMV; Salgarello, M	1
Cho, JY; Han, HS; Lee, WW; Suh, MS; Yoo, MY; Yoon, YS	1
Chang, X; Fu, C; Huo, L; Lv, J; Wang, X	1
Gallinger, S; Jhaveri, KS; Menezes, R; Metser, U; Razaz, S; Sagheb, S	1
Farahmandfar, F; Moradian, S; Sadeghi, R; Shahlaei, S; Shakeri, S	1
Hotta, M; Minamimoto, R; Motoi, F; Takanami, K; Takase, K; Toyama, Y	1
Byun, Y; Choi, Y; Han, Y; Jang, JY; Kang, J; Kim, H; Kwon, W; Moon, D	1
Ahopelto, K; Böckelman, C; Haglund, C; Hagström, J; Kauhanen, S; Saukkonen, K; Seppänen, H	1
Lee, JH	1
Fujimoto, K; Mitamura, K; Nishiyama, Y; Norikane, T; Okano, K; Suzuki, Y; Yamamoto, Y	1
Chen, L; Lv, J; Shi, H; Xiu, Y; Yin, H	1
He, T; Sun, J; Tian, R; Wang, H; Zhang, W	1
Blaszkowsky, LS; Cañamaque, LG; Catalano, OA; Clark, JW; Fernandez-Del Castillo, C; Ferrone, CR; Furtado, FS; Groshar, D; Hong, TS; Lee, SI; Qadan, M; Rosman, DA; Ryan, DP; Striar, R; Umutlu, L; Vangel, M; Weekes, C	1
Liu, C; Song, Y; Wang, PY; Wang, XM; Zheng, Y	1
Bassi, C; Bianchi, B; Cingarlini, S; Crinò, SF; D'Onofrio, M; Deiro, G; Landoni, L; Manfrin, E; Montagnini, G; Paiella, S; Parisi, A; Salgarello, M; Salvia, R; Tebaldi, S; Zuffante, M	1
Bodei, L; Bongiovanni, A; Caroli, P; Cittanti, C; Di Iorio, V; Diano, D; Grana, CM; Grassi, I; Ibrahim, T; Monti, M; Nicolini, S; Paganelli, G; Pieri, F; Sansovini, M; Sarnelli, A; Severi, S	1
Cai, L; Chen, Y; Deng, M	1
Datta-Gupta, S; Garg, P; Kumar, R; Sharma, A; Sharma, R	1
Pan, Y; Xie, J; Zhang, Y; Zhou, J	1
Cheng, C; Li, M; Liu, Z; Peng, Y; Ren, S; Shen, J; Sun, G; Yang, X; Yang, Z; Zuo, C	1
Bjerring, OS; Fristrup, CW; Hess, S; Lundell, L; Mortensen, MB; Petersen, H	1
Kim, K; Kim, SJ	1
Dang, H; Liu, H; Tian, J; Wang, G; Wu, Y; Xu, B; Yao, S; Ye, H; Yu, P	1
Gao, J; Gong, R; Gong, Y; Li, Z; Ma, Y; Yang, J; Zhu, J	1
Bergamo, F; Cassarino, G; Cecchin, D; Evangelista, L; Moletta, L; Pegoraro, N; Serafini, S; Sperti, C; Zucchetta, P	1
Cheng, S; Cheng, Z; Song, S; Zhu, X; Zou, S	1
Chang, HM; Hwang, DW; Jeong, JH; Jun, E; Kim, JS; Kim, KP; Kim, SC; Kwon, JW; Lee, JH; Lee, W; Oh, M; Park, SY; Park, Y; Ryoo, BY; Song, KB; Yoo, C	1
Chen, Y; Liu, H; Zhang, W; Zhang, Y	1
Bohmer, R; Burgess, JR; Kornaczewski Jackson, ER; Pointon, OP	1
Akita, H; Fujiwara, Y; Ishikawa, O; Kobayashi, S; Miyata, H; Miyoshi, N; Moon, JH; Ohigashi, H; Ohue, M; Omori, T; Sakon, M; Sugimura, K; Takahashi, H; Tomokuni, A; Yano, M; Yasui, M	1
Blandamura, S; Passuello, N; Pozza, G; Sperti, C; Valmasoni, M	1
Farahani, ZA; Hess, S; Tind, S; Vestergaard, S	1
Cheng, AP; Fu, JL; Fu, LP; Jin, L; Wang, XG	1
Bhasin, DK; Das, A; Gupta, R; Mittal, BR; Nada, R; Rana, SS; Santhosh, S	1
Eguchi, H; Hatazawa, J; Hori, M; Nakamoto, A; Onishi, H; Ota, T; Sakane, M; Tatsumi, M; Tomiyama, N; Tsuboyama, T; Wakasa, K	1
Cheedella, N; Hinson, S; Li, L; Lucas, E; Molberg, K; Thibodeaux, J	1
Byanju, S; Chen, J; Liao, M; Wang, L; Wang, Y; Zhang, H; Zhu, D	1
Basturk, O; Corrias, G; Mannelli, L; Ragucci, M; Saba, L	1
Balachandran, A; Bhosale, P; Katz, M; Rayamajhi, S; Reddy, A; Rohren, E	1
Guo, N; Hu, G; Li, F; Luo, Y; Ma, Y	1
Belfiori, G; Crippa, S; Falconi, M; Partelli, S; Pergolini, I; Pucci, A; Ruffo, G; Salgarello, M; Zamboni, G	1
Mahajan, S; Pandit-Taskar, N	1
Qin, L; Zhang, C; Zhang, Y	1
Capurso, G; Delle Fave, G; Falconi, M; Iannicelli, E; Merola, E; Muffatti, F; Panzuto, F; Partelli, S; Pizzichini, P; Prosperi, D; Rinzivillo, M; Salgarello, M; Schillaci, O; Scopinaro, F	1
Ariake, K; Fukase, K; Hayashi, H; Maeda, S; Masuda, K; Mizuma, M; Motoi, F; Naitoh, T; Ohtsuka, H; Shimomura, H; Takadate, T; Taki, Y; Tatewaki, Y; Terao, C; Unno, M	1
Dercle, L; Garg, I; Goenka, AH; Hough, DM; Wang, ZJ; Yeh, R	1
Davidson, M; Ewton, AA; Olsen, RJ; Robbins, RJ	1
Huo, L; Li, F; Xing, H; Zheng, L	1
Fukukura, Y; Kajiya, Y; Kitazono, M; Nagano, H; Nakajo, M; Niihara, T; Suenaga, T; Tanaka, S; Tani, A; Toyota, M; Yoshiura, T	1
Cárdenas-Rodríguez, J; Goldenberg, JM; Pagel, MD	1
Gupta, V; Kumar, R; Mittal, BR; Parihar, AS; Singh, H	1
Hu, Q; Ji, S; Liang, C; Liang, D; Liu, J; Liu, W; Meng, Q; Ni, Q; Qin, Y; Shi, S; Xiang, J; Xu, J; Xu, W; Yu, X; Zhang, B	1
Chen, YC; Cheng, MF; Guo, YL; Ko, CL; Liao, WC; Liu, CJ; Tien, YW; Wang, HP; Wu, YW; Yen, RF	1
Castaldi, P; Inzani, F; Lorusso, M; Menghi, R; Rindi, G; Rufini, V; Schinzari, G	1
Beatty, GL; Chen, F; Gladney, WL; June, CH; Kulikovskaya, IM; Lacey, SF; Levine, BL; McGarvey, M; Melenhorst, JJ; Nazimuddin, F; Nelson, AM; O'Hara, MH; Plesa, G; Soulen, MC; Torigian, DA	1
Ando, Y; Kamada, H; Kobara, H; Masaki, T; Nagao, M; Okano, K; Okita, Y; Okuyama, H; Oshima, M; Suto, H; Suzuki, Y; Tsuji, A	1
Li, Y; Tan, X; Wang, G; Xu, W; Yang, Y; Yang, Z	1
Bissoli, S; Fantin, A; Moletta, L; Passuello, N; Sperti, C; Valmasoni, M	1
Bahrami, A; Bohl, CE; Federico, SM; Robinson, GW; Shulkin, BL	1
Albano, D; Alongi, P; Familiari, D; Fornito, MC; Galia, M; Gentile, R; Messina, M; Midiri, F; Midiri, M; Scalisi, S; Spada, M	1
Belli, ML; Bettinardi, V; Broggi, S; Calandrino, R; Cattaneo, GM; Dell'Oca, I; Di Muzio, N; Fallanca, F; Fiorino, C; Mori, M; Passoni, P; Picchio, M; Vanoli, EG	1
Kim, HR; Nah, YW; Park, HW; Park, SH; Seo, M	1
Ishigame, T; Kofunato, Y; Murakami, Y; Nakano, K; Okada, R; Shimura, T; Suzuki, S; Takenoshita, S; Yashima, R	1
Buckel, E; Ferrario, M; Guevara, DL; Pavez, G; Romero, C; Tapia, V; Zapata, J	1
Ichikawa, S; Motosugi, U; Nakajima, N; Omiya, Y; Onishi, H; Satoh, Y	1
Behr, S; Cinar, P; Collisson, EA; Consunji, MV; Gao, K; Ko, AH; Ohliger, MA; Tempero, MA; Wang, ZJ; Yeh, BM	1
Chung, YA; Lee, JW; Lee, SM	1
Borel Rinkes, IH; Daamen, LA; Goense, L; Groot, VP; Intven, MPW; Molenaar, IQ; van Santvoort, HC; Wessels, FJ	1
Choi, SH; Park, SW; Seong, J	1
Li, F; Li, J; Luo, Y; Pan, Q; Zhang, S	1
Chen, X; Fu, Z; Li, Q; Yang, X	1
Balasse, L; Bouhlel, A; Ding, L; Fernandez, S; Garrigue, P; Giorgio, S; Guillet, B; Huang, Y; Iovanna, J; Lan, W; Laurini, E; Liu, X; Lyu, Z; Marson, D; Mas, E; Peng, L; Pricl, S; Tang, J; Tintaru, A; Weng, Y; Zhang, M	1
Arigami, T; Iino, S; Kawasaki, Y; Kijima, Y; Kurahara, H; Maemura, K; Mataki, Y; Mori, S; Natsugoe, S; Sakoda, M; Shinchi, H; Ueno, S	1
Hwang, HK; Kang, CM; Lee, SH; Lee, WJ; Yun, M	2
Adachi, T; Eguchi, S; Ideguchi, R; Kudo, T; Myssayev, A; Sumida, Y; Tobinaga, S; Uetani, M	1
Cheng, MF; Ho, BY; Hsin, LW; Huang, YY; Jeng, YM; Kuo, HC; Kuo, TC; Shiue, CY; Tien, YW; Yen, RF	1
Cuccurullo, V; Di Stasio, GD; Mansi, L	1
Kan, Y; Liu, J; Wang, W; Yang, J; Yang, X	1
Jiang, L; Li, D; Li, X; Ren, S; Yuan, Y; Zhang, A; Zhu, X; Zuo, C	1
Fukushi, M; Inoue, K; Kishimoto, S; Minamimoto, R; Mitsumoto, T; Sunaoka, F	1
Bekaii-Saab, TS; Collins, JM; Hopp, AC; Yang, M	1
Deng, S; Fan, G; Luan, Y; Peng, M; Qin, X; Wan, R; Wu, Y; Wu, Z; Xu, L	1
Hou, B; Hu, Y; Huo, L; Xing, H; Zhao, Y	1
Garg, I; Goenka, AH; Halfdanarson, TR; Johnson, GB; Panda, A; Truty, MJ	1
Bang, YJ; Cheon, GJ; Kang, SY; Oh, DY; Yoo, SH	1
Liu, C; Liu, ET; Sun, TT; Wang, HL; Wang, SX	1
Cavaliere, A; Cecchin, D; Giraudo, C; Quaia, E; Zuliani, M	1
Armani, M; Cadiot, G; Couvelard, A; Cros, J; de Mestier, L; Hentic, O; Lebtahi, R; Rebours, V; Ruszniewski, P; Sauvanet, A	1
Broggi, S; Calandrino, R; Cattaneo, M; Di Muzio, N; Fiorino, C; Gianolli, L; Gumina, C; Incerti, E; Mapelli, P; Passoni, P; Picchio, M; Reni, M; Slim, N; Vanoli, EG; Zanon, S	1
Büchler, MW; Strobel, O	1
Abe, S; Ikeda, M; Itoh, S; Iwano, S; Kato, K; Naganawa, S; Nihashi, T; Shimamoto, K	1
Agrawal, A; Kulkarni, M; Purandare, N; Rangarajan, V; Shah, S; Zade, A	1
Giaccari, A; Petrone, G; Rindi, G; Rufini, V; Salomone, E; Treglia, G	1
Hu, SL; Ping, B; Yang, ZY; Yu, XJ; Zhang, YJ; Zhou, ZR	1
Okano, K; Oshima, M; Suzuki, Y; Yachida, S; Yamamoto, N	1
Arita, H; Chijiiwa, K; Fujita, S; Furukoji, E; Futami, S; Kawai, K; Kiyohara, S; Mizutani, Y; Nagamachi, S; Nishii, R; Sakae, T; Tamura, S; Wakamatsu, H	1
Cho, SB; Chung, CY; Joo, YE; Kim, JS; Lee, WS; Min, JJ; Myung, DS; Park, HC	1
Freesmeyer, M; Marlowe, RJ; Sänger, P; Schierz, JH	1
Kawaguchi, M; Minamiguchi, S; Nakamoto, Y; Nakatani, K; Someya, Y; Togashi, K	1
Chevallier, P; Legmann, P; Prat, F; Taieb, D; Tenenbaum, F	1
Chu, Q; Hamidian Jahromi, A; Martin, B; Sangster, G; Shi, R; Shokouh-Amiri, H; Takalkar, A; Zibari, G	1
Beriwal, S; Fulay, S; Kabolizadeh, P	1
Ikeda, S; Ito, T; Kanazawa, H; Katada, N; Morita, K; Narita, M; Nishimura, D; Okubo, K; Shibahara, H; Takeuchi, A	1
Chen, JQ; Huang, Y; Liu, JL; Qin, XG; Wang, Z	1
Nissen, NN; Pitts, A; Waxman, A; Yu, R	1
Cha, JM; Joo, KR; Lim, JU; Moon, SY; Shin, HP; So, YR; Yang, YJ	1
Cui, Y; Dong, A; Gao, L; Wang, Y; Yang, J; Zuo, C	1
Cho, A; Choi, HJ; Kang, CM; Kim, JH; Lee, JD; Lee, JH; Lee, WJ; Song, SY; Yun, M	1
Bal, C; Gupta, SK; Karunanithi, S; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Patnecha, M; Reddy, RM; Sharma, P	1
Parlak, C; Topkan, E; Yapar, AF	1
Kim, SK; Kim, YI; Lee, HY; Paeng, JC	1
Alavi, A; Saboury, B; Salavati, A	1
Dimitrakopoulou-Strauss, A; Epelbaum, R; Frenkel, A	1
Honda, H; Kamada, T; Shinoto, M; Shioyama, Y; Tsujii, H; Yamada, S; Yasuda, S; Yoshikawa, K	1
Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C	1
Kebebew, E; Liu, Y; Sadowski, SM; Summers, RM; Weisbrod, AB; Yao, J	1
Chen, RH; Chen, T; Liu, C; Liu, L; Long, J; Wang, WQ; Wu, CT; Xu, HX; Xu, J; Yu, XJ; Zhang, YJ	1
Jambawaliker, S; Krishnamoorthy, SK; Saif, MW	1
Ahn, SJ; Kang, WJ; Lee, JD; Park, MS	1
Alimchandani, M; Ellis, R; Kebebew, E; Linehan, WM; Millo, C; Nilubol, N; Patel, D; Quezado, M; Sadowski, SM; Venzon, DJ; Weisbrod, AB	1
Bando, Y; Harada, M; Ikushima, H; Kubo, M; Matsuzaki, K; Nose, H; Otomi, Y; Otsuka, H; Terazawa, K	1
Choi, HJ; Kang, CM; Lee, JD; Lee, JH; Lee, JW; Lee, WJ; Song, SY	1
Castelli, P; Crippa, S; Falconi, M; Laiti, S; Partelli, S; Salgarello, M; Spinelli, AE; Tamburrino, D; Zamboni, G	1
Chang, DT; Chaudhry, M; Dholakia, AS; Griffith, ME; Hacker-Prietz, A; Herman, JM; Koong, AC; Laheru, DA; Leal, JP; Oteiza, KE; Pai, J; Pawlik, T; Raman, SP; Su, Z; Tryggestad, E; Wahl, RL; Wolfgang, CL	1
Duivenvoorden, HJ; Rijkers, AP; Valkema, R; van Eijck, CH	1
Dalah, E; Erickson, B; Li, XA; Moraru, I; Paulson, E	1
Besse, H; Chassagnon, G; Gauvain, S; Metrard, G	1
Alluri, KC; Chaudhry, M; Chirindel, A; Lodge, MA; Subramaniam, RM; Tahari, AK; Wahl, RL	1
Adler, L; Biersack, HJ; Ezziddin, S; Fischer, HP; Grabellus, F; Höller, T; Nagarajah, J; Pöppel, TD; Sabet, A; Simon, B; Yüce, A	1
Allendorf, JD; Chabot, JA; Einersen, P; Epelboym, I; Leung, D; Winner, MD	1
Brunner, TB; Chu, KY; Hawkins, M; Mukherjee, S; Partridge, M; Wilson, JM	1
Chang, JS; Cho, A; Choi, SH; Kim, KH; Lee, JD; Lee, Y; Park, JY; Seong, J; Song, SY; Yun, M	1
Bhasin, D; Bhattacharya, A; Gupta, R; Mittal, BR; Nada, R; Rana, SS; Santhosh, S; Srinivasan, R	1
Bomanji, J; Panagiotidis, E	1
Endo, I; Inoue, T; Tateishi, U; Yoneyama, T	1
Dai, T; Popa, E; Shah, MA	1
Guo, M; Hu, S; Huang, D; Jin, K; Liu, C; Liu, L; Liu, Z; Long, J; Luo, G; Ni, Q; Xiao, Z; Xu, J; Yu, X; Zhang, B	1
Guo, R; Hu, J; Li, B; Xi, Y; Zhang, M; Zhang, X	1
Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kinoshita, H; Kitasato, Y; Okabe, Y; Okuda, K; Tanaka, H; Yasunaga, M	1
Aramaki, T; Endo, M; Mizuno, T; Okamura, Y; Sugiura, T; Uesaka, K; Yamamoto, T	1
Akhurst, T; Eu, P; Hicks, RJ; Hofman, MS; Kashyap, R; Kong, G; Michael, M; Zannino, D	1
Mortensen, MB	1
Chen, Y; Huang, Z; Rao, M; Zhang, L; Zhu, Y	1
Eguchi, H; Hatazawa, J; Hori, M; Kim, T; Nagano, H; Nakamoto, A; Onishi, H; Sakane, M; Tatsumi, M; Tomiyama, N; Wakasa, K	1
Bahri, H; Boucher, E; Clement, B; Cuggia, M; Devillers, A; Edeline, J; Garin, E; Laurence, L; Leghzali, H; Mesbah, H; Raoul, JL	1
Bhasin, D; Bhattacharya, A; Das, A; Mittal, BR; Rana, SS; Santhosh, S; Srinivasan, R	1
Delle Fave, G; Falconi, M; Maurizi, A; Panzuto, F; Partelli, S; Polenta, V; Rinzivillo, M; Salgarello, M	1
Doki, Y; Eguchi, H; Hama, N; Kawamoto, K; Kim, T; Kobayashi, S; Mori, M; Morii, E; Nagano, H; Tatsumi, M; Tomimaru, Y; Wada, H	1
Adalet, I; Aykan, F; Has Simsek, D; Kuyumcu, S; Sanlı, Y; Turkmen, C; Unal, S	1
Choi, HJ; Kang, B; Lee, JD; Lee, JH; Lee, JW; Song, SY	1
Wang, WL; Ye, S; Zhao, K	1
Schillaci, O	1
Dai, M; Hu, W; Huo, L; Li, F; Luo, Y; Wu, H; Xue, H; Zhao, Y	1
Cho, JY; Chung, KH; Han, HS; Hwang, DW; Hwang, JH; Lee, SH; Park, JK; Yoon, YS	1
Ji, S; Liu, C; Liu, J; Liu, L; Long, J; Ni, Q; Qin, Y; Shi, S; Xu, J; Xu, W; Yu, X; Zhang, B	1
Marangmei, C; Sharma, P	1
Fu, DL; Guan, YH; Jin, C; Wang, XY; Yang, F; Zhang, HW	1
Kawai, K; Kobayashi, M; Kusanagi, K; Mizutani, A; Nakajima, S; Ogura, M; Okui, Y; Sagara, J; Shikano, N; Yamaguchi, N	1
Chen, Y; Fishman, EK; Raman, SP	1
Cheng, C; Hu, S; Liu, Q; Sun, G; Zhang, J; Zuo, C	1
Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H	1
Hicks, RJ; Hofman, MS; Kashyap, R; Michael, M	1
Arisawa, T; Hosoki, T; Kawada, N; Shiroeda, H; Takami, M; Tomita, Y; Uehara, H	1
Nesterov, DV; Rozengauz, EV	1
Akcam, AT; Demiryürek, H; Doran, F; Okoh, AK; Parsak, CK; Rencuzoğulları, A; Ülkü, A; Yapar, Z	1
Bo, J; Deng, M; Fan, G; Luan, Y; Peng, M; Wan, R; Xu, L	1
Barajas, M; Collantes, M; Ecay, M; Escalada, J; Martí-Climent, JM; Peñuelas, I; Quincoces, G; Ramos-Membrive, R; Rodríguez, S	1
Alluri, KC; Chaudhry, MA; Chirindel, A; Herman, JM; Pawlik, TM; Subramaniam, RM; Wahl, RL	1
Edeline, J; Garin, E	1
Bryant, R; Burge, ME; Cavallucci, D; Eastgate, M; Finch, R; Francesconi, A; Hopkins, G; Houston, K; Macfarlane, D; O'Rourke, N; Thomas, P; Wyld, D	1
Gong, LL; Li, XX; Liu, NB; Ren, P; Wang, P; Xu, WG; Yang, CW; Yuan, XK; Zhao, LJ; Zhu, L	1
Lysanyuk, MV; Maistrenko, NA; Romashchenko, PN	1
Alanen, K; Grönroos, J; Gullichsen, R; Kajander, S; Kauhanen, S; Kemppainen, J; Nuutila, P; Ovaska, J; Rinta-Kiikka, I; Seppänen, M	1
Donswijk, ML; Hess, S; Lam, MG; Mulders, T	1
Hodul, P; Kim, J; Kim, R; Kothari, N; Mahipal, A; Malafa, M; Morse, B; Prithviraj, G; Springett, G; Yue, B	1
Marcus, C; Parikh, U; Sarangi, R; Subramaniam, RM; Taghipour, M	1
Kumar, A; Kumar, R; Shamim, SA	1
Dang, CV; de Wilde, RF; Dutta, P; Gillies, RJ; Hidalgo, M; Jain, SK; Kamphorst, JJ; Le, A; Maitra, A; Martinez, GV; Rabinowitz, JD; Rajeshkumar, NV; Yabuuchi, S	1
Fujimura, T; Fushida, S; Hayashi, H; Kitagawa, H; Makino, I; Miyashita, T; Nakagawara, H; Nakanuma, S; Ninomiya, I; Ohbatake, Y; Ohta, T; Tajima, H; Takamura, H	1
Kebebew, E; Summers, RM; Wong, KC; Yao, J	1
Cao, S; Chen, XD; Chi, F; Jin, XY; Sun, YN; Tang, MY; Wang, SL; Wu, R	1
Dahlman, A; Fröhlich, C; Horak, ID; Jacobsen, HJ; Jensen, MM; Kjaer, A; Kragh, M; Kristensen, LK; Lantto, J; Nielsen, CH; Poulsen, TT	1
Mena, E; Rahmim, A; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R; Young, B	1
Brentnall, TA; Chen, R; Jeffrey, RB; Laeseke, PF; Willmann, JK	1
Albert, NL; Bartenstein, P; Boeck, S; Fendler, WP; Heinemann, V; Ilhan, H; Lehner, S; Michl, M; Paprottka, PM	1
Ashrafinia, S; Jackson, A; Marcus, C; Rahmim, A; Schmidtlein, CR; Sheikhbahaei, S; Soltani, M; Subramaniam, RM	1
Chen, K; Chen, Y; Hu, S; Huang, W; Lin, X; Liu, Y; Shi, X; Song, Q; Wang, Z	1
Berman, CG; Chen, DT; Davis-Yadley, AH; Eikman, EA; Kim, RD; Malafa, MP; Pimiento, JM	1
Abbott, AM; Chen, DT; Davis-Yadley, AH; Malafa, MP; Pimiento, JM	1
Chang, J; Chang, YR; Jang, JY; Jung, W; Kang, MJ; Kim, SW; Shin, YC	1
Danno, K; Fujitani, K; Iwase, K; Kubota, M; Matsuda, C; Miyazaki, S; Motoori, M; Nakatsuka, R; Nishimura, M	1
Bilski, M; Duchnowska, R; Hryciuk, B; Kamiński, G; Szczylik, C; Szymanowski, B; Łapińska, G	1
Agrawal, K; Gupta, R; Kaman, L; Kochhar, R; Mittal, BR; Singh, R; Singh, V; Verma, GR; Vineeth Kumar, PM	1
Chiba, T; Haga, H; Hatano, E; Isoda, H; Kodama, Y; Kurita, A; Kuriyama, K; Minamiguchi, S; Nakamoto, Y; Sawai, Y; Togashi, K; Uemoto, S; Uza, N; Yoshimura, K	1
Chiao, PJ; Huang, R; Ji, S; Jin, K; Li, M; Liang, C; Liang, D; Liu, C; Liu, J; Liu, L; Ni, Q; Qin, Y; Shi, S; Xu, J; Xu, W; Yu, X; Zhang, B	1
Chang, MC; Chang, YT; Chen, BB; Chen, XJ; Cheng, MF; Kuo, TC; Lai, HS; Shih, IL; Shih, TT; Tien, YW; Wu, CH; Yang, SH	1
Cano-Valderrama, O; Caruso, R; Díaz, E; Durán, HJ; Fabra, I; Garcia, L; Ielpo, B; Malavé, L; Quijano, Y; Vicente, E	1
Apers, S; Capistrano, R; Dockx, Y; Lardon, F; Pauwels, P; Pieters, L; Staelens, S; Stroobants, S; Vangestel, C; Wouters, A	1
Cho, SK; Hwang, HK; Kang, CM; Kim, C; Lee, WJ; Park, J; Yun, M	1
Cheon, GJ; Chung, JK; Im, HJ; Jang, JY; Jung, W; Kang, KW; Kim, EE; Kim, SW; Lee, DS; Oo, S	1
Chiorean, EG; Korn, RL; Liu, H; Ramanathan, RK; Von Hoff, DD	1
Aung, W; Furukawa, T; Kouda, K; Kurosawa, Y; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB; Ukai, Y	1
Bektasoglu, H; Durmus, A; Ertugrul, G; Karatepe, O; Karyagar, S; Malya, F; Ozturk, G; Yilmaz, A	1
Hiraoka, M; Itasaka, S; Kishi, T; Matsuo, Y; Mizowaki, T; Nakamoto, Y; Nakamura, A; Togashi, K	1
Alagappan, M; Chang, DT; Cui, Y; Koong, AC; Li, R; Pollom, E; Shirato, H; Song, J	1
Basuroy, R; Ramage, JK; Srirajaskanthan, R	1
Bélissant Benesty, O; Cassou-Mounat, T; Montravers, F; Talbot, JN; Vatier, C	1
Honda, Y; Nagasaki, Y; Ochi, N; Takigawa, N; Yamane, H	1
Azuma, K; Hattori, S; Ishibashi, M; Ishii, K; Kage, M; Kaida, H; Kawahara, A; Kitasato, Y; Murakami, T; Taira, T; Ureshino, H; Yasunaga, M	1
Bodei, L; Bongiovanni, A; Cingarlini, S; Fantini, L; Ferroni, F; Grana, CM; Ianniello, A; Mezzenga, E; Monti, M; Nicolini, S; Paganelli, G; Sansovini, M; Scarpi, E; Severi, S	1
Claver Valderas, MA; de la Peña Moral, J; Frutos Esteban, L; Fuster Quiñonero, M; García-Pérez, R; Ortiz Ruiz, E; Parrilla Paricio, P; Sánchez-Bueno, F	1
Copin, D; D'Hulst, L; De Spiegeleer, B; Delcourt, A; Maes, A; Van de Wiele, C; Van Vlaenderen, M	1
Feng, F; Huo, L; Jin, Z; Li, F; Liao, Q; Zhao, Y	1
Jha, AK; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Vicente, E; Xiao, J	1
Bassi, C; Butturini, G; Capelli, P; Cingarlini, S; Citton, E; Davì, MV; De Robertis, R; DʼOnofrio, M; Grego, E; Malfatti, V; Malpaga, A; Ortolani, S; Ruzzenente, A; Salgarello, M; Scarpa, A; Tortora, G; Trentin, C; Vallerio, P	1
Ishii, A; Kondo, T; Nakamoto, Y; Oka, T; Takaori-Kondo, A	1
Chan, M; Schembri, GP	1
Hayami, S; Hirono, S; Kawai, M; Kitahata, Y; Kojima, F; Miyazawa, M; Okada, KI; Shimizu, A; Ueno, M; Yamaue, H	1
Halbrook, CJ; Lyssiotis, CA	1
Jiang, L; Nie, H; Shi, H; Xiu, Y; Zhu, L	1
Bui, C; Hennessy, G; Le, K; Loh, H; Mansberg, R; Vamadevan, S	1
Baba, H; Chikamoto, A; Hashimoto, D; Inoue, R; Komohara, Y; Sakamaki, K; Shiraishi, S; Takamori, H; Yamanaka, T; Yamashita, Y; Yamashita, YI; Yoshida, N	1
Brunner, TB; Hawkins, MA; Mukherjee, S; Partridge, M; Wilson, JM	1
Chong, JU; Hwang, HK; Kang, CM; Lee, JH; Lee, WJ; Yun, M	1
Cheon, GJ; Chung, JK; Goo, JM; Kang, KW; Lee, DS; Lee, JM; Lee, SJ; Paeng, JC	1
Fukuda, S; Gomi, T; Hoashi, T; Katsura, N; Kawai, Y; Okumura, K; Satoh, M; Shimizu, K; Takebayashi, K	1
Gotohda, N; Kinoshita, T; Konishi, M; Nakagohri, T; Takahashi, S	1
Belinc, D; Chen, DT; Eikman, EA; Farma, JM; Malafa, M; Melis, M; Santillan, AA; Walters, J	1
Cornfeld, D; Modarresifar, H; Ojha, B; Saif, MW	1
Baiocchi, GL; Bertagna, F; Gheza, F; Giubbini, R; Giulini, SM; Pizzocaro, C; Portolani, N	1
Prabhakar, HB; Rabinowitz, CB; Sahani, DV	1
Adam, G; Ammerpohl, O; Brenner, W; Buchert, R; Egberts, JH; Grutzmann, R; Henze, E; Kalthoff, H; Mikecz, P; Niedzielska, D; Peldschus, K; Pilarsky, C; Schumacher, U; von Forstner, C	1
Al Haddad, M; Aranda-Michel, J; Bonatti, H; Dougherty, M; Fitzpatrick, P; Hinder, R; Huguet, K; Kim, G; Martin, K; McLaughlin, S; Nguyen, JH; Stockland, A	1
Bhure, U; Clavien, PA; Hany, TF; Heinrich, S; Pestalozzi, BC; Soyka, J; Strobel, K; Veit-Haibach, P	1
Birkfellner, T; Juergens, KU; Rahbar, K; Weckesser, M; Wienbeck, S	1
Almusa, O; Daly, B; Shreve, P	1
Campbell, P; Kok, J; Lin, M; Lin, P; Wong, V	1
Arizono, S; Doi, R; Haga, H; Hirokawa, Y; Isoda, H; Maetani, Y; Nakamoto, Y; Nitta, T; Shimada, K; Togashi, K; Yamashita, R	1
Pavlovskiĭ, AV; Popov, SA; Ryzhkova, DV; Tiutin, LA; Tlostanova, MS	1
Doi, R; Hatano, E; Higashi, T; Kami, K; Machimoto, T; Masui, T; Ogawa, K; Seo, S; Uemoto, S	1
Chierichetti, F; Fassan, M; Parenti, AR; Pasquali, C; Pedrazzoli, S; Pizzi, S; Sperti, C	1
Bennewith, KL; Erler, JT; Feazell, J; Giaccia, AJ; Graves, EE; Ham, CM; Huang, X; Kambham, N; Koong, A; Yang, GP	1
Arakawa, Y; Hanaoka, J; Ikegami, T; Imura, S; Kanemura, H; Mori, H; Morine, Y; Nishi, M; Shimada, M; Sugimoto, K	1
Amemiya, R; Asato, Y; Hashimoto, I; Iijima, H; Kaburagi, T; Kaito, K; Kiyoshima, M; Okumura, T; Sato, M; Uchiumi, K	1
Reske, SN	1
Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nishii, R; Tamura, S; Wakamatsu, H	1
Abe, K; Ishida, K; Mitamura, A; Miyazaki, S; Takahashi, S; Takanami, K; Yamada, S	1
Ford, JM; Humke, E; Kim, J; Koong, AC; Quon, A	1
Asaka, M; Eto, K; Haba, S; Kawakami, H; Kuwatani, M; Shiga, T; Tamaki, N	1
Kim, JS; Kim, MH; Lee, KT; Lee, SK; Lee, TY; Park, DH; Seo, DW	1
Alanen, K; Borra, RJ; Dean, KI; Kajander, SA; Kauhanen, SP; Komar, G; Minn, HR; Nuutila, P; Ovaska, JT; Puolakkainen, PA; Rinta-Kiikka, I; Seppänen, MP	1
Aburano, T; Chen, Z; Tian, M; Ye, X; Zhan, H; Zhang, H; Zhang, Y; Zhao, C	1
Kajander, S; Kauhanen, S; Komar, G; Liukko, K; Minn, H; Nuutila, P; Ovaska, J; Seppänen, M	1
Bhatia, V; El-Amin, H; Hara, K; Mizuno, N; Nishio, M; Sawaki, A; Sayed, Zel-A; Shigekawa, M; Takagi, T; Tamaki, T; Yamao, K	1
Bissoli, S; Chierichetti, F; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Autio, A; Härkönen, P; Lehikoinen, P; Luoto, P; Roivainen, A; Salomäki, S; Sipilä, H; Tolvanen, T; Ujula, T; Viljanen, T	1
Choi, M; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Venkatramanamoorthy, R; Zalupski, MM	1
Huang, G; Liu, J; Liu, T; Pan, L; Song, S; Tang, S; Treven, L; Zhang, C; Zhang, T	1
Kaji, Y; Kitajima, K; Kubota, K; Murakami, K; Shimoda, M; Suganuma, N; Sugimura, K; Yamasaki, E	1
Kurahara, H; Maemura, K; Mataki, Y; Natsugoe, S; Noma, H; Shinchi, H; Takao, S	1
Borschitz, T; Eichhorn, W; Fottner, C; Hansen, T; Lang, H; Musholt, TJ; Schad, A; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM	1
Chang, DT; Fisher, GA; Ford, JM; Goodman, KA; Graves, EE; Koong, AC; Kunz, P; Minn, AY; Quon, A; Schellenberg, D	1
Hyodo, M; Kasahara, N; Koizumi, M; Morishima, K; Sakuma, Y; Sasanuma, H; Sata, N; Shimizu, A; Yasuda, Y	1
Alkadhi, H; Donati, O; Fischer, MA; Hany, TF; Heinrich, S; Marincek, B; Scheffel, H; Soldini, D; Weber, A	1
Delbeke, D; Martin, WH	1
Nguyen, BD; Ram, PC	1
Doi, R; Imai, H; Isoda, H; Iwanaga, Y; Kamo, N; Kanazawa, H; Kawaguchi, Y; Koizumi, M; Masui, T; Takada, Y; Uemoto, S	1
Donati, OF; Fornaro, J; Hany, TF; Marincek, B; Reiner, CS; von Schulthess, GK; Weishaupt, D	1
Ikehira, H; Kamada, T; Kato, A; Miyazaki, M; Mizoe, J; Obata, T; Saga, T; Shiraishi, T; Tanimoto, K; Watanabe, K; Yoshikawa, K	1
Izuishi, K; Masaki, T; Sano, T; Suzuki, Y; Takebayashi, R; Yamamoto, Y	1
Barber, TW; Cherk, MH; Evans, P; Kalff, V; Kelly, MJ; Yap, KS	1
Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T	1
Aono, S; Inoue, T; Ohta, K; Sakai, S; Sugawara, Y; Takahashi, T; Tanada, M; Teramoto, N	1
Doki, Y; Eguchi, H; Kim, T; Kitagawa, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Takeda, Y; Tanemura, M; Tatsumi, M; Tomimaru, Y; Umeshita, K; Wakasa, K	1
Ansquer, C; Frampas, E; Meurette, G; Pery, C; Regenet, N	1
Choi, SK; Park, CH	1
Jang, SJ; Kim, KA; Kim, MJ	1
Cho, A; Choi, JY; Choi, YJ; Hong, HS; Kim, KW; Kim, MJ; Lee, JD; Yun, M	1
Bomanji, J; Caplin, M; Desai, K; Quigley, AM; Toumpanakis, C; Watkins, J; Woodward, N	1
Aikawa, M; Imabayashi, E; Koyama, I; Matsuda, H; Miyazawa, M; Okada, K; Okamoto, K; Toshimitsu, Y	1
Cancian, L; Cugini, C; Morana, G; Pozzi Mucelli, R	1
Chaudhry, MA; Leach, SD; Serrano, OK	1
Buriánková, E; Havlík, R; Klos, D; Koranda, P; Kysucan, J; Lovecek, M; Neoral, C; Tozzi, I	1
Billotey, C; Borson-Chazot, F; Bournaud, C; Cornu, C; Giammarile, F; Hervieu, V; Houzard, C; Janier, M; Le Bars, D; Lombard-Bohas, C; Masson, S; Scoazec, JY; Vuillez, JP; Walter, T	1
Addeo, P; Becker, CD; Bucher, P; Buchs, NC; Bühler, L; Frossard, JL; Morel, P; Ratib, O; Rosset, A; Roth, AD; Terraz, S; Willi, JP	1
Hiyama, T; Iijima, T; Kato, K; Nagai, H; Saito, H; Sato, M; Shirasu, T; Yoshimi, F	1
Jeong Yoon, S; Lee, B; Park, CH	1
Cenkowski, M; Czaykowski, PM; Gibson, IW; Lategan, B	1
Akamoto, S; Hagiike, M; Kakinoki, K; Nishiyama, Y; Okano, K; Suzuki, Y; Usuki, H; Yamamoto, Y	1
Kita, M; Kitajima, K; Maeda, T; Ohno, Y; Onishi, Y; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T	1
Beer, AJ; Buck, AK; Eckel, F; Herrmann, K	1
Hatazawa, J; Higuchi, I; Hori, M; Inoue, A; Isohashi, K; Kim, T; Onishi, H; Shimosegawa, E; Takeda, Y; Tatsumi, M	1
Bartsch, DK; Fendrich, V; Jacobsen, ID; Maitra, A; Opfermann, T; Schneider, R	1
Bartholomeusz, DF; Nguyen, NQ	1
Cameron, K; Golan, S; Kostakoglu, L; Labow, D; Peti, S; Roayaie, S; Simpson, W	1
Han, SS; Kim, SK; Kim, TS; Lee, JW; Lee, SM; Park, SJ	1
Brouwers, AH; de Vries, EG; Fiebrich, HB; Hospers, GA; Links, TP; Remkes, WS; Siemerink, EJ	1
Grassetto, G; Rubello, D	1
Fineberg, N; Grizzle, WE; Kim, H; Knowles, JA; Rosenthal, EL; Shah, N; Stockard, CR; Zhai, G; Zhou, T; Zinn, KR	1
Asmussen, JT; Bjerregaard, JK; Fischer, BM; Hansen, CR; Høilund-Carlsen, PF; Mortensen, MB; Petersen, H; Pfeiffer, P; Vilstrup, MH	1
Lam, WW; Loi, HY; Loke, KS; Padhy, AK	1
Barthel, JS; Eikman, EA; Keshishian, J; Klapman, JB; Lin, JL	1
Desai, B; Elatre, W; Jadvar, H; Quinn, DI	1
Nguyen, BD; Nguyen, CC; Nguyen, VX	1
Kotek, A; Parlak, C; Pehlivan, B; Topkan, E; Yapar, AF	1
Bissoli, S; Chierichetti, F; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Gesuwan, K; Herscovitch, P; Hughes, MS; Kebebew, E; Kitano, M; Libutti, SK; Linehan, WM; Millo, C; Nilubol, N; Phan, GQ; Rahbari, R; Venkatesan, AM; Webb, RC	1
Shah, MA; Smyth, EC	1
Fineberg, NS; Kim, H; Rana, S; Rigell, CJ; Samuel, SL; Stockard, CR; Umphrey, HR; Zhai, G; Zinn, KR	1
Belião, S; Blocklet, D; Ferreira, A; Goldman, S; Matos, C; Metens, T; Vierasu, I	1
Abe, M; Azemoto, N; Furukawa, S; Hiasa, Y; Ikeda, Y; Koizumi, M; Kumagi, T; Kuroda, T; Kushihata, F; Matsuura, B; Onji, M; Soga, Y; Watanabe, J; Yamanishi, H; Yokota, T	1
Beer, AJ; Buck, AK; Dobritz, M; Erkan, M; Friess, H; Herrmann, K; Kleeff, J; Schmid, RM; Schuster, T; Schwaiger, M; Siveke, JT; Wester, HJ	1
Chen, J; Hu, JN; Hua, J; Liu, MJ; Wu, LM; Xu, JR	1
Onal, C; Parlak, C; Reyhan, M; Selek, U; Topkan, E	1
Fujii, H; Hayakawa, T; Imai, T; Kimura, S; Mutoh, M; Tsuda, K; Umeda, IO; Wakabayashi, K; Yoshimoto, M	1
Farlow, D; Gan, G; Hollands, M; Lam, VW; Laurence, JM; Pleass, HC; Richardson, A; Yao, J	1
Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V	1
Jadvar, H	1
Azadi, J; Durand, DJ; Subhawong, A	1
Codreanu, I; Servaes, S; Yang, J; Zhuang, H	1
Choi, DW; Choi, SH; Heo, JS; Kim, MJ; Ku, BH; Lee, JK; Lee, KH; Lee, KT; Oh, CR	1
Asagi, A; Iguchi, H; Inoue, T; Nadano, S; Nasu, J; Nishimura, R; Ohta, K; Tanada, M; Teramoto, N; Yamamoto, K	1
Baiocchi, GL; Bertagna, F; Calanducci, D; Gheza, F; Giubbini, R; Giulini, SM; Grazioli, L; Portolani, N	1
Gotoh, K; Hasegawa, Y; Ishikawa, O; Kittaka, H; Ohigashi, H; Takahashi, H; Tomita, Y; Yamada, T; Yano, M	1
Dibble, EH; Kachnic, LA; Karantanis, D; Mercier, G; Peller, PJ; Subramaniam, RM	1
Andersson, R; Ansari, D; Keussen, I	1
Dimitrakopoulou-Strauss, A; Epelbaum, R; Frenkel, A; Haddad, R; Israel, O; Sikorski, N; Strauss, LG	1
Baba, S; Hiraide, T; Inaba, K; Konno, H; Morita, Y; Sakaguchi, T; Shibasaki, Y; Suzuki, A; Suzuki, S; Tokuyama, T	1
Campbell, EM; Ee, H; Francis, RJ; Morandeau, L; Robins, PD; Segard, T; Yusoff, IF	1
Callea, F; Caporale, N; Giordano, A; Locatelli, F; Rufini, V; Treglia, G	1
Campitiello, M; Plastino, F; Treglia, G	1
Bhasin, D; Bhattacharya, A; Das, A; Gupta, R; Kapoor, R; Mittal, BR; Nada, R; Rana, S; Santhosh, S; Srinivasan, R	1
Baiocchi, GL; Bertagna, F; Giubbini, R; Treglia, G	1
Cheng, C; Dong, A; Dong, H; Wang, Y; Zhang, J; Zuo, C	1
Decker, M; Eckel, F; Frank, R; Helmberger, H; Lersch, C; Lippl, F; Neverve, J; Schulte-Frohlinde, E; Schusdziarra, V; Schwaiger, M; Weber, W	1
Clark, LA; Clary, BM; Coleman, RE; Gottfried, M; Kalady, MF; Pappas, TN; Rohren, EM; Tyler, DS	1
Barrier, A; Houry, S; Huguier, M; Montravers, F; Talbot, JN; Valinas, R	1
Deichen, JT; Gack, M; Kuwert, T; Prante, O; Schmiedehausen, K	1
Keith, CJ; Miles, KA; Wong, D	1
Alavi, A; Anderson, GS; Brinkmann, F; Soulen, MC; Zhuang, H	1
Ambo, Y; Hirano, S; Katoh, C; Katoh, H; Kondo, S; Noji, T; Tamaki, N; Tanaka, E; Tsukamoto, E	1
Lin, EC; Studley, M	1
Buell, U; Zimmy, M	1
Bourguet, P	1
Chin, BB; Wahl, RL	1
Gottschild, D; Opfermann, T; Voth, M	1
Boland, GW; Fischman, AJ; Kalra, MK; Maher, MM; Saini, S	1
Constable, CJ; Fulham, MJ; McCaughan, BC; Wilkinson, MD	1
Doi, R; Fujimoto, K; Higashi, T; Imamura, M; Ishimori, T; Konishi, J; Nakamoto, Y; Saga, T	1
Higashi, T; Imamura, M; Ishimori, T; Ishizu, K; Kobayashi, H; Konishi, J; Mamede, M; Nakamoto, Y; Saga, T; Sakahara, H; Sato, N	1
Annovazzi, A; Dierckx, R; Maenhout, A; Peeters, M; Signore, A; Van De Wiele, C	1
Chierichetti, F; Decet, G; Ferronato, A; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS	1
Andoh, H; Asanuma, Y; Furuya, T; Hatazawa, J; Koyama, K; Sato, T; Shibata, S; Yoshioka, M	1
Andoh, H; Asanuma, Y; Furuya, T; Hatazawa, J; Koyama, K; Sato, T; Shibata, S; Shimosegawa, E; Yamamoto, Y; Yoshioka, M	1
Balzarini, L; Chiti, A; Lucignani, G; Malesci, A	1
Amthauer, H; Felix, R; Oettle, H; Pelzer, U; Plotkin, M; Ruf, J; Scholman, HJ; Steinmüller, T; Wust, P	1
Amthauer, H; Boehmig, M; Felix, R; Hosten, N; Lemke, AJ; Niehues, SM; Rohlfing, T; Rosewicz, S; Stroszczynski, C	1
Lee, MH; Yoon, JK; Yoon, SN	1
Doi, R; Fujimoto, K; Higashi, T; Imamura, M; Lyshchik, A; Nakamoto, Y; Saga, T	1
Canessa, JA; Galaz, R; González, P; Humeres, P; Jofré, J; Larach, JA; Massardo, T; Morales, B; Parra, J; Sierralta, P	1
Zimny, M	1
Hustinx, R	1
Haglund, U; Långström, B; Rasmussen, I; Sörensen, J	1
de Castro, S; Drenth, JP; Jansen, JB; Oyen, WJ; van Goor, H; van Kouwen, MC	1
Kulasingam, SL; Matchar, DB; Orlando, LA	1
Chierichetti, F; Decet, G; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Hellwig, D; Kirsch, CM; Menger, MD; Menges, M; Moellers, MO; Romeike, BF; Samnick, S; Schneider, G	1
Lee, JK; Tyan, YS	1
Delbeke, D; Pinson, CW	1
Divgi, C; Pandit-Taskar, N	1
Huang, B; Puri, S	1
Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M; Tutor, C	1
Bosonnet, L; Connor, S; Evans, J; Garvey, CJ; Ghaneh, P; Hughes, M; Jayan, R; Lytras, D; Neoptolemos, JP; Sutton, R; Vinjamuri, S	1
Amthauer, H; Felix, R; Lopez Hänninen, E; Oettle, H; Pelzer, U; Plotkin, M; Ruf, J; Stroszczynski, C	1
Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S	1
Drenth, JP; Jansen, JB; Laverman, P; Oyen, WJ; van Kouwen, MC; van Krieken, JH	1
Arai, T; Ebata, T; Hiromatsu, T; Nagino, M; Nimura, Y; Nishio, H; Oda, K; Yokoyama, Y; Yuasa, N	1
Bauerfeind, P; Clavien, PA; Goerres, GW; Hany, TF; Heinrich, S; Pestalozzi, BC; Sagmeister, M; Schäfer, M; von Schulthess, GK	1
Nguyen, BD	1
Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Tsutsui, K; Wakabayashi, H; Yamamoto, Y	1
Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Tsutsui, K; Yamamoto, Y; Yokoe, K	1
Hany, TF; Strobel, K; Thuerl, CM	1
Feuerbach, S; Hamer, OW	1
Chierichetti, F; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Bissoli, S; Chierichetti, F; Fiore, V; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Ell, PJ; Groves, AM; Pakzad, F	1
Asato, Y; Imura, J; Kawasaki, H; Mise, Y; Nakajima, K; Okumura, T; Sato, M; Shioyama, Y; Takasaka, I; Yoshimi, F	1
Akechi, T; Akizuki, N; Fujimori, M; Furuse, J; Inagaki, M; Kinoshita, T; Kobayakawa, M; Matsuoka, Y; Murakami, K; Nakano, T; Sugawara, Y; Uchitomi, Y; Yoshikawa, E	1
Chan, AT; Chan, SL; Hui, EP; Leung, SF; Ma, BB	1
Amthauer, H; Böhmig, M; Denecke, T; Felix, R; Koch, I; Langrehr, J; Lopez Hänninen, E; Plotkin, M; Ruf, J; Wiedenmann, B	1
Allen, PJ; Brennan, MF; D'Angelica, M; Fong, Y; Larson, SM; Mansour, JC; Pandit-Taskar, N; Schwartz, L	1
de Boer, J; Hoogenberg, K; Jager, PL; Machteld Wymenga, AN; Nieboer, P; Pras, E; Sleijfer, DT; Suurmeijer, AJ; van der Graaf, WT; Wiggers, T	1
Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N	1
Armbruster, C; Feichtinger, H; Gschwantler, M; Kriwanek, S; Kroiss, A; Moeschl, P; Plattner, D; Roka, R; Schueller, J; Singer, E; Weiss, W	1
Chung, YF; Goh, BK; Ng, DC; Selvarajan, S; Soo, KC	1
Kim, EE; Ng, CS; Tamm, EP	1
Enomoto, M; Habu, D; Higashiyama, S; Kawabe, J; Kawada, N; Kawamura, E; Nakayama, Y; Shimonishi, Y; Shiomi, S; Tamori, A; Tsushima, H	1
Jennings, SG; McHenry, L; Sandrasegaran, K; Schmidt, CM; Skandarajah, A; Tann, M	1
Bissoli, S; Chierichetti, F; Frison, L; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Izuishi, K; Nishiyama, Y; Okano, K; Otani, T; Sano, T; Suzuki, Y; Wakabayashi, H; Yachida, S	1
Abe, Y; Fujisawa, T; Fujita, K; Inamori, M; Kirikoshi, H; Kobayashi, N; Kubota, K; Nakajima, A; Saito, S; Takahashi, H; Yoneda, M	1
Aizawa, T; Arakura, N; Hamano, H; Kadoya, M; Kawa, S; Kiyosawa, K; Miyata, K; Momose, M; Muraki, T; Oguchi, K; Ozaki, Y	1
Fujisawa, M; Kai, K; Toshikuni, N	1
Brouwers, AH; de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; Vanghillewe, K	1
Buchmann, I; Ganten, TM; Haberkorn, U	1
Beyna, T; Domschke, W; Franzius, C; Heindel, W; Juergens, KU; Oei, ML; Pohle, T; Schick, V; Schnekenburger, J; Schober, O; Weckesser, M	1
Adler, AC; Haddad, R; Keidar, Z; Lachter, J	1
Benyounes, H; Bruce, D; Campbell, C; Eremin, O; Evans, NT; Heys, SD; Mikecz, P; Norton, MY; Sharp, PF; Smith, FW	1
Fukatsu, H; Ikeda, M; Ishigaki, T; Isomura, T; Ito, K; Ito, S; Kato, T; Nishino, M; Ota, T; Tadokoro, M	1
Hawkins, RA	1
Berger, HG; Friess, H; Glatting, G; Kocher, F; Reske, SN; Stollfuss, JC	1
Fujii, M; Imamura, M; Inokuma, T; Kajiyama, T; Konishi, J; Magata, Y; Ohshio, G; Tamaki, N; Torizuka, T; Yonekura, Y	1
Beger, HG; Büchler, MW; Ebert, M; Friess, H; Langhans, J; Reske, SN; Stollfuss, J	1
Fujita, T; Imamura, M; Inokuma, T; Konishi, J; Magata, Y; Ohshio, G; Tamaki, N; Torizuka, T; Yonekura, Y	1
Bares, R; Büll, U; Cremerius, U; Fass, J; Hauptmann, S; Hellwig, D; Klever, P; Mittermayer, C; Schumpelick, V	1
Bares, R; Buell, U; Fass, J; Hambuechen, U; Hauptmann, S; Hellwig, D; Klever, P; Mueller, B; Schumpelick, V; Zopp, L	1
Bradfield, H; Gupta, N	1
Bares, R; Büll, U; Cremerius, U; Dohmen, BM; Fass, J; Teusch, M	1
Akhurst, T; Berlangieri, S; Bishop, J; Hannah, A; McKay, WJ; Scott, AM	1
Chung, YS; Kawabe, J; Nakata, B; Nishihara, T; Nishimura, S; Ochi, H; Okamura, T; Sakurai, Y; Sawada, T; Sowa, M	1
Adam, G; Bares, R; Buell, U; Cremerius, U; Dohmen, B; Fass, J; Klever, P; Sabri, O; Schumpelick, V; Zimny, M	1
Higashi, T; Honda, T; Hosotani, R; Imamura, M; Inokuma, T; Kimura, T; Konishi, J; Ohshio, G; Tamaki, N; Torizuka, T	1
Beger, HG; Gansauge, F; Glatting, G; Grillenberger, KG; Hildebrandt, M; Port, M; Reske, SN	1
Adams, S; Baum, R; Hör, G; Rink, T; Schumm-Dräger, PM; Usadel, KH	1
Beger, HG; Diederichs, CG; Glatting, G; Reske, SN; Staib, L	1
Baum, RP; Dietrich, C; Hör, G; Kirchner, J; Rink, T; Schröder, O; Zeuzem, S	1
Higashi, T; Honda, T; Imamura, M; Inokuma, T; Katsushima, S; Kimura, T; Konishi, J; Nakamoto, Y; Ohshio, G; Sakahara, H; Tamaki, N; Torizuka, T	1
Faulhaber, PF; Miraldi, F; Rajput, A; Stellato, TA; Vesselle, HJ	1
Branch, MS; Clark, L; Coleman, RE; DeLong, DM; Keogan, MT; McDermott, VG; Tyler, D	1
Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H	1
Franzius, C; Schober, O; Sciuk, J	1
Avril, N; Roder, JD; Schwaiger, M; Sendler, A; Siewert, JR	1
Beger, HG; Diederichs, CG; Fröhlich, A; Reske, SN; Staib, L; Vogel, J	1
Boos, S; Einert, A; Farthmann, EH; Högerle, S; Imdahl, A; Krautmann, F; Nitzsche, E; Sontheimer, J	1
Higashi, T; Imamura, M; Kogire, M; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N	1
Beauchamp, RD; Chapman, WC; Delbeke, D; Frexes, ME; Leach, SD; Pinson, CW; Richards, WO; Rose, DM; Sandler, MP; Sharp, KW; Wright, JK	1
Buell, U; Zimny, M	1
Beger, HG; Berberat, P; Büchler, MW; Friess, H; Kashiwagi, M	1
Higashi, T; Hiraoka, M; Imamura, M; Kanamori, S; Konishi, J; Nakamoto, Y; Nishimura, Y; Sakahara, H; Tamaki, N; Torizuka, T	1
Delbeke, D	1
Beauchamp, RD; Chapman, WC; Delbeke, D; Leach, SD; Pinson, CW; Rose, DM; Shyr, Y; Wright, JK	1
Higashi, T; Imamura, M; Itoh, K; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N	1
Daenen, F; Detroz, B; Honoré, P; Hustinx, R; Jacquet, N; Paulus, P; Rigo, P	1
Beger, HG; Brambs, HJ; Diederichs, CG; Glasbrenner, B; Glatting, G; Reske, SN; Staib, L; Vogel, J	1
Belhocine, T; Daenen, F; Focan, C; Honoré, P; Hustinx, R; Rigo, P	1
Price, P	1
Cunningham, DC; Flux, GD; Maisey, NR; Norman, A; Ott, RJ; Padhani, A; Webb, A	1
Bihl, H; Lang, O	1
Beyer, T; Brun, T; Byars, L; Charron, M; Jerin, J; Kinahan, PE; Nutt, R; Roddy, R; Townsend, DW; Young, J	1
Delbeke, D; Leach, SD; Mertz, HR; Sechopoulos, P	1
Bares, R; Buechin, P; Buell, U; Cremerius, U; Fass, J; Sabri, O; Schumpelick, V; Zimny, M	1
Avril, N; Bengel, F; Helmberger, H; Roder, JD; Schwaiger, M; Sendler, A; Siewert, JR; Stollfuss, J; Weber, W	1
Böhmig, M; Hosten, N; Lemke, AJ; Rosewicz, S; Wiedenmann, B	1
Bacchella, T; Costa, AC; Cunha, JE; Halpern-Salomon, I; Jukemura, J; Machado, MC; Penteado, S	1
Doi, R; Higashi, T; Hosotani, R; Imamura, M; Kogire, M; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N	1
Birk, D; Buchmann, I; Buck, AC; Diederichs, CG; Guhlmann, CA; Kotzerke, J; Mattfeldt, T; Reske, SN; Schirrmeister, HH; Shen, C	1
Glatting, G; Greten, FR; Neumaier, B; Reske, SN; Schmid, RM; Seitz, U; Vogg, AT; Wagner, M	1
Fawwaz, RA; van Heertum, RL	1
Hirakawa, K; Ishikawa, T; Kawabe, J; Nakata, B; Nishimura, S; Nishino, H; Ochi, H; Ohira, M	1
Chung, KH; Kawabe, J; Koyama, K; Nakata, B; Ochi, H; Okamura, T; Yamada, R	1
Habu, D; Ishizu, H; Iwata, Y; Kawabe, J; Kurooka, H; Minamitani, S; Nishiguchi, S; Ochi, H; Shiomi, S	1
Higashiyama, S; Inoue, Y; Kawabe, J; Koyama, K; Ochi, H; Ohachi, Y; Okamura, T; Sakamoto, H; Shakudo, M; Yamada, R	1
Schumpelick, V; Zimny, M	1
Chierichetti, F; Ferlin, G; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C	1
Bombardieri, E; Chiti, A; De Deckere, E; Maccauro, M; Savelli, G	1
Doi, R; Higashi, T; Hosotani, R; Imamura, M; Ishimori, T; Konishi, J; Mamede, MH; Nakamoto, Y; Saga, T; Wada, M	1
Ambrus, E; Csernay, L; Farkas, G; Lonovics, J; Papós, M; Pávics, L; Szakáll, S; Takács, T; Trón, L	2
Hanbidge, AE	1
Del Frate, C; Mortele, K; Ros, PR; Zanardi, R	1
Brink, I; Hoegerle, S; Imdahl, A; Mix, M; Moser, E; Nitzsche, EU; Otte, A	1
Bares, R; Büll, U; Fass, J; Klever, P; Schumpelick, V	1

Reviews

84 review(s) available for fluorodeoxyglucose f18 and Cancer of Pancreas

Article	Year
Effect of metformin on The British journal of radiology, 2022, Feb-01, Volume: 95, Issue:1130 Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; Diabetes Mellitus, Type 2; Energy Intake; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney; Liver Neoplasms; Metformin; Mice; Myocardium; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Thyroid Neoplasms; White Matter	2022
Comparison of Preoperative Imaging Modalities for the Assessment of Malignant Potential of Pancreatic Cystic Lesions: A Network Meta-analysis. Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Network Meta-Analysis; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity	2022
18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies. PET clinics, 2022, Volume: 17, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
CT, MRI, and BMC medical imaging, 2022, 12-29, Volume: 22, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2022
Gastro-Entero-Pancreatic Tumors: FDG Positron Emission Tomography/Computed Tomography. PET clinics, 2023, Volume: 18, Issue:2 Topics: Copper Radioisotopes; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin	2023
Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. PET clinics, 2023, Volume: 18, Issue:3 Topics: Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Radiolabeled FAPI in pancreatic cancer: can it be an additional value in the management of patients? Expert review of anticancer therapy, 2023, Volume: 23, Issue:7 Topics: Databases, Factual; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Quinolines	2023
PET/MRI for evaluation of patients with pancreatic cancer. Abdominal radiology (New York), 2023, Volume: 48, Issue:12 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2023
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2023, Jun-08 Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing	2023
18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging? Diagnostic and interventional imaging, 2019, Volume: 100, Issue:12 Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Patient Care Planning; Patient Selection; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals	2019
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma: A Meta-analysis. Pancreas, 2019, Volume: 48, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Outcome Assessment, Health Care; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals	2019
The Role of PET/CT in the Imaging of Pancreatic Neoplasms. Seminars in ultrasound, CT, and MR, 2019, Volume: 40, Issue:6 Topics: Adenocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis. Acta radiologica (Stockholm, Sweden : 1987), 2020, Volume: 61, Issue:11 Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2020
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review. Clinical imaging, 2020, Volume: 67 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Stomach Neoplasms	2020
Diagnostic Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Characterization of Intraductal Papillary Mucinous Neoplasms: An Updated Systematic Review and Meta-analysis. Pancreas, 2021, 03-01, Volume: 50, Issue:3 Topics: Adenocarcinoma, Mucinous; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2021
The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review. Annals of nuclear medicine, 2021, Volume: 35, Issue:7 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2021
Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges. Minerva chirurgica, 2017, Volume: 72, Issue:5 Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms	2017
Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis. Medicine, 2017, Volume: 96, Issue:33 Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2017
Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: Two case reports and literature review. Medicine, 2017, Volume: 96, Issue:38 Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2017
The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdominal radiology (New York), 2018, Volume: 43, Issue:2 Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Patient Care Planning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2018
PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms	2017
Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures. Clinical journal of gastroenterology, 2018, Volume: 11, Issue:6 Topics: Aged, 80 and over; Carcinoma, Papillary; Chemotherapy, Adjuvant; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms	2018
The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis. European journal of radiology, 2018, Volume: 106 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2018
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours. Current radiopharmaceuticals, 2019, Volume: 12, Issue:2 Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin	2019
Molecular radionuclide imaging of pancreatic neoplasms. The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:7 Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Forecasting; Genes, Neoplasm; Humans; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals	2019
[An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:6 Topics: Aged; Antimetabolites, Antineoplastic; Autopsy; Carcinoma; Drug Combinations; Fatal Outcome; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Oxonic Acid; Pancreatic Neoplasms; Pleurisy; Positron-Emission Tomography; Tegafur	2013
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis. World journal of gastroenterology, 2013, Aug-07, Volume: 19, Issue:29 Topics: Carcinoma; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals	2013
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology, 2014, Volume: 99, Issue:2 Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography	2014
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:7 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors. PET clinics, 2014, Volume: 9, Issue:1 Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Enterochromaffin Cells; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms	2014
The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies. Current treatment options in oncology, 2014, Volume: 15, Issue:3 Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Upper Gastrointestinal Tract	2014
Novel imaging strategies for upper gastrointestinal tract cancers. Expert review of gastroenterology & hepatology, 2015, Volume: 9, Issue:3 Topics: Diagnostic Imaging; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed	2015
Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET/CT scan: an atlas with pathologic correlation. Abdominal imaging, 2015, Volume: 40, Issue:5 Topics: Adolescent; Adult; Aged; Ampulla of Vater; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:10 Topics: Adult; Biopsy; Diagnosis, Differential; Epithelioid Cells; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Multimodal Imaging; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sclerosis; Tomography, X-Ray Computed; Treatment Outcome	2014
Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation. Seminars in oncology, 2015, Volume: 42, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
[The current state of radiologic diagnosis in pancreatic cancer]. Voprosy onkologii, 2014, Volume: 60, Issue:5 Topics: Cholangiopancreatography, Endoscopic Retrograde; Cholangiopancreatography, Magnetic Resonance; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies. PET clinics, 2014, Volume: 9, Issue:4 Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed	2014
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes. PET clinics, 2015, Volume: 10, Issue:3 Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2015
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes. PET clinics, 2015, Volume: 10, Issue:3 Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed	2015
Neuroendocrine Tumors. Gastroenterology clinics of North America, 2016, Volume: 45, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Procedures; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Metastasectomy; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Serotonin; Tomography, X-Ray Computed	2016
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. Cancer cell, 2017, 01-09, Volume: 31, Issue:1 Topics: Carcinoma, Pancreatic Ductal; Cellular Reprogramming; Fluorodeoxyglucose F18; Glucose; Glutamine; Humans; Metformin; Pancreatic Neoplasms; Positron-Emission Tomography; Tumor Microenvironment	2017
Recent advances in imaging of pancreatic neoplasms. Cancer treatment and research, 2008, Volume: 143 Topics: Adenocarcinoma; Diagnostic Imaging; Endoscopy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Medical Oncology; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography	2008
[PET and PET-CT of malignant tumors of the exocrine pancreas]. Der Radiologe, 2009, Volume: 49, Issue:2 Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2009
Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis. European journal of radiology, 2011, Volume: 78, Issue:1 Topics: Endosonography; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions. Gastroenterologie clinique et biologique, 2010, Volume: 34, Issue:8-9 Topics: Adenocarcinoma; Cystadenocarcinoma; Cystadenoma; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2010
Staging cancer of the pancreas. Cancer imaging : the official publication of the International Cancer Imaging Society, 2010, Oct-04, Volume: 10 Spec no A Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
The role of PET scanning in pancreatic cancer. Advances in surgery, 2010, Volume: 44 Topics: Carcinoma, Pancreatic Ductal; Endosonography; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2010
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdominal imaging, 2011, Volume: 36, Issue:4 Topics: Carcinoma; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
¹⁸F-FDG PET/CT imaging of the pancreas: spectrum of diseases. JOP : Journal of the pancreas, 2011, Nov-09, Volume: 12, Issue:6 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World journal of gastroenterology, 2011, Dec-14, Volume: 17, Issue:46 Topics: Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Stomach Neoplasms	2011
Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:6 Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdominal imaging, 2012, Volume: 37, Issue:6 Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers. Seminars in nuclear medicine, 2012, Volume: 42, Issue:4 Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Stomach Neoplasms	2012
PET/CT of cancer patients: part 1, pancreatic neoplasms. AJR. American journal of roentgenology, 2012, Volume: 199, Issue:5 Topics: Cost-Benefit Analysis; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls. Scandinavian journal of gastroenterology, 2013, Volume: 48, Issue:3 Topics: Biliary Tract Neoplasms; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Pancreatic metastases of cerebellar hemangiopericytoma occurring 24 years after initial presentation: report of a case. Surgery today, 2014, Volume: 44, Issue:3 Topics: Aged; Cerebellar Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Hemangiopericytoma; Humans; Magnetic Resonance Imaging; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2014
F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature. Japanese journal of radiology, 2013, Volume: 31, Issue:4 Topics: Adenocarcinoma, Mucinous; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms]. Bulletin du cancer, 2003, Volume: 90 Spec No Topics: Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed	2003
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut, 2003, Volume: 52 Suppl 4 Topics: Adult; Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed	2003
[The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions]. Zentralblatt fur Chirurgie, 2003, Volume: 128, Issue:5 Topics: Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications. AJR. American journal of roentgenology, 2003, Volume: 181, Issue:2 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality". Annals of nuclear medicine, 2003, Volume: 17, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Patient Selection; Practice Patterns, Physicians'; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting	2003
18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract. Gastroenterology, 2003, Volume: 125, Issue:4 Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Pancreatic Neoplasms; Tomography, Emission-Computed	2003
Diagnostic imaging of pancreatic cancer--the role of PET. Frontiers of radiation therapy and oncology, 2004, Volume: 38 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Tomography, Emission-Computed	2004
PET imaging in assessing gastrointestinal tumors. Radiologic clinics of North America, 2004, Volume: 42, Issue:6 Topics: Carcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2004
Meta-analysis: the detection of pancreatic malignancy with positron emission tomography. Alimentary pharmacology & therapeutics, 2004, Nov-15, Volume: 20, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2004
Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. Journal of hepato-biliary-pancreatic surgery, 2004, Volume: 11, Issue:1 Topics: Adenocarcinoma; Biopsy, Fine-Needle; Cholangiopancreatography, Magnetic Resonance; Diagnostic Imaging; Endosonography; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2004
How much intravenous contrast is needed in FDG-PET/CT? Nuklearmedizin. Nuclear medicine, 2005, Volume: 44 Suppl 1 Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
The role of positron emission tomography in the management of pancreatic cancer. Seminars in nuclear medicine, 2006, Volume: 36, Issue:3 Topics: Adenocarcinoma; Adult; Case Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography	2006
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)]. Bulletin du cancer, 2007, Volume: 94, Issue:2 Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms	2007
Imaging of neuroendocrine tumors. Hematology/oncology clinics of North America, 2007, Volume: 21, Issue:3 Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Paraganglioma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2007
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors]. Zeitschrift fur Gastroenterologie, 2008, Volume: 46, Issue:4 Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
[Role of 18F-FDG positron emission tomography in surgical evaluation]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 1998, Volume: 115 Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	1998
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Annals of surgery, 1999, Volume: 229, Issue:5 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	1999
18FDG-positron emission tomography in pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10 Suppl 4 Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Tomography, Emission-Computed	1999
Diagnosis and staging of pancreatic cancer by positron emission tomography. World journal of surgery, 1999, Volume: 23, Issue:9 Topics: Adenocarcinoma; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Oncological applications of FDG PET imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:10 Topics: Breast Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	1999
[Role of positron emission tomography is the evaluation of digestive tract tumors]. Revue medicale de Liege, 1999, Volume: 54, Issue:12 Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed	1999
Changes in 18F-FDG uptake measured by PET as a pharmacodynamic end-point in anticancer therapy. How far have we got? British journal of cancer, 2000, Volume: 83, Issue:3 Topics: Antineoplastic Agents; Europe; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Pancreatic Neoplasms; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed	2000
The role of nuclear medicine in the evaluation of pancreatic disease. The Surgical clinics of North America, 2001, Volume: 81, Issue:2 Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pancreatic Diseases; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed	2001
[Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2001, Volume: 72, Issue:9 Topics: Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Pancreatic Neoplasms; Pancreatitis; Patient Selection; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
Nuclear medicine imaging of neuroendocrine tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12 Suppl 2 Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed	2001
Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US? Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2002, Volume: 16, Issue:2 Topics: Adenocarcinoma; Diagnostic Imaging; Endosonography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Advances in imaging for pancreatic disease. Current gastroenterology reports, 2002, Volume: 4, Issue:2 Topics: Adenocarcinoma; Adenoma, Islet Cell; Cystadenoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Cyst; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002

Trials

34 trial(s) available for fluorodeoxyglucose f18 and Cancer of Pancreas

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2023, Jun-08 Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing	2023
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol. PloS one, 2023, Volume: 18, Issue:11 Topics: Adenocarcinoma; Adult; Carcinoma, Pancreatic Ductal; Clinical Trials, Phase II as Topic; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multicenter Studies as Topic; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose ( Asia-Pacific journal of clinical oncology, 2020, Volume: 16, Issue:3 Topics: Adult; Aged; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate	2020
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11). Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021, Volume: 197, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Chemotherapy, Adjuvant; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Oxaliplatin; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:10 Topics: Capecitabine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies	2021
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial. Gastroenterology, 2018, Volume: 155, Issue:1 Topics: Aged; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Immunotherapy, Adoptive; Male; Mesothelin; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Antigen, T-Cell; RNA, Messenger; Survival Rate; T-Lymphocytes; Transplantation, Autologous	2018
Prospective comparison of (4S)-4-(3- European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:4 Topics: Adenocarcinoma; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glutamates; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Safety	2019
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy. International journal of radiation oncology, biology, physics, 2014, Jul-01, Volume: 89, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Blood Glucose; Carcinoma, Pancreatic Ductal; Deoxycytidine; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Gemcitabine; Glycolysis; Humans; Induction Chemotherapy; Liver; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Regression Analysis; Tomography, X-Ray Computed; Tumor Burden	2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome	2015
Correlation of Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, Volume: 29, Issue:6 Topics: Adult; Aged; Area Under Curve; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden	2017
Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:9 Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Iohexol; Pancreatic Neoplasms; Patient Selection; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2008
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer. American journal of clinical oncology, 2010, Volume: 33, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Monitoring; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Neoadjuvant Therapy; Neutrons; Pancreatectomy; Pancreatic Neoplasms; Photons; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Treatment Outcome	2010
18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours. Nuclear medicine communications, 2011, Volume: 32, Issue:2 Topics: Adult; Aged; Cell Differentiation; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms	2011
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery, 2011, Volume: 150, Issue:6 Topics: Adolescent; Adult; Aged; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease; Young Adult	2011
Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed. Annals of surgical oncology, 2012, Volume: 19, Issue:11 Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Confidence Intervals; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals	2012
Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2013
Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer. Clinical nuclear medicine, 2013, Volume: 38, Issue:1 Topics: Adult; Aged; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Monitoring of tumour glucose metabolism by PET in a phase I study evaluating hormonal therapy in advanced pancreatic cancer. Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Glucose; Hormone Antagonists; Humans; Indoleacetic Acids; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Cholecystokinin; Thiazoles; Tomography, Emission-Computed	2002
Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose. Annals of nuclear medicine, 2003, Volume: 17, Issue:5 Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed	2003
Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Severity of Illness Index; Survival Analysis; Survival Rate	2005
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:4 Topics: Carcinoma; Chronic Disease; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2005
Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2005, Volume: 5, Issue:2-3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nuclear medicine communications, 2005, Volume: 26, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors	2005
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Annals of nuclear medicine, 2005, Volume: 19, Issue:6 Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting	2005
Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World journal of gastroenterology, 2008, Jan-07, Volume: 14, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity	2008
Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Endoscopic Retrograde; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Ultrasonography	2008
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. European journal of nuclear medicine, 1998, Volume: 25, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Radiopharmaceuticals; Stomach Neoplasms; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed	1998
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Annals of surgery, 1999, Volume: 229, Issue:5 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	1999
Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
[18FDG-PET imaging of pancreatic adenocarcinoma]. Revue medicale de Liege, 2000, Volume: 55, Issue:2 Topics: Adenocarcinoma; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2000
FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. British journal of cancer, 2000, Volume: 83, Issue:3 Topics: Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasm, Residual; Pancreatic Neoplasms; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2000
Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:8 Topics: Adenocarcinoma; Aged; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Pancreatic Neoplasms; Probability; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Tomography, Emission-Computed	2000
Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer, 2000, Dec-15, Volume: 89, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed	2000

Other Studies

436 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Pancreas

Article	Year
Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer. Pancreas, 2021, 08-01, Volume: 50, Issue:7 Topics: Aged; Autoimmune Pancreatitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity	2021
A fare case of pancreatic metastasis from malignant melanoma mimicking pancreatitis on Journal of the Egyptian National Cancer Institute, 2021, 10-11, Volume: 33, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020). The Journal of small animal practice, 2022, Volume: 63, Issue:3 Topics: Animals; Dog Diseases; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer. Clinical nuclear medicine, 2022, Jan-01, Volume: 47, Issue:1 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Muscles; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines	2022
177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma. Clinical nuclear medicine, 2022, Mar-01, Volume: 47, Issue:3 Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2022
Pancreatic Acinar Cell Carcinoma Presenting with Diffuse Pancreatic Enlargement. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:3 Topics: Carcinoma, Acinar Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Pancreas; Pancreatic Neoplasms	2022
Roles of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET/CT, CA19-9 levels, and complete blood count parameters in predicting survival in patients with unresectable or metastatic pancreatic cancer. Annali italiani di chirurgia, 2022, Volume: 93 Topics: Blood Cell Count; CA-19-9 Antigen; Fluorodeoxyglucose F18; Glycolysis; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2022
Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer. Molecular imaging and biology, 2022, Volume: 24, Issue:4 Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Early Detection of Cancer; Fluorodeoxyglucose F18; Integrin alphaVbeta3; Mice; Oligopeptides; Pancreatic Neoplasms; Positron-Emission Tomography; Tissue Distribution	2022
Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy. Journal of surgical oncology, 2022, Volume: 126, Issue:2 Topics: CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Prognosis; Retrospective Studies	2022
Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[ Clinical radiology, 2022, Volume: 77, Issue:6 Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Glucose; Humans; Necrosis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
[A Case of Resection of Pancreatic Body Cancer Successfully Treated with GEM plus Nab-PTX]. Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2022
Metastasis From Clear Cell Renal Cell Carcinoma Mimicking Well-Differentiated Pancreatic Neuroendocrine Tumor at 18F-FDG and 68Ga-DOTATOC PET/CT. Clinical nuclear medicine, 2022, Jul-01, Volume: 47, Issue:7 Topics: Aged, 80 and over; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neuroectodermal Tumors, Primitive; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2022
68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer. Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines	2022
The Significance of FDG PET/CT-Derived Parameters in Determining Prognosis of Cases with Pancreatic Adenocarcinoma: A Prospective Study. Medicina (Kaunas, Lithuania), 2022, Aug-01, Volume: 58, Issue:8 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Matrix Metalloproteinase 2; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies	2022
The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancer. Contrast media & molecular imaging, 2022, Volume: 2022 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2022
68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report. Medicine, 2022, Aug-26, Volume: 101, Issue:34 Topics: Congenital Hyperinsulinism; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Middle Aged; Multiple Endocrine Neoplasia Type 1; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging	2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN, 2022, Volume: 20, Issue:9 Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Prognosis; Retrospective Studies	2022
Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates. Abdominal radiology (New York), 2022, Volume: 47, Issue:12 Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Receptors, Somatostatin	2022
Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection. Scientific reports, 2022, 10-14, Volume: 12, Issue:1 Topics: Adenocarcinoma; CA-19-9 Antigen; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2022
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors. Clinical nuclear medicine, 2023, Jan-01, Volume: 48, Issue:1 Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2023
18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma. ANZ journal of surgery, 2023, Volume: 93, Issue:1-2 Topics: Adenocarcinoma; Aged; Fluorides; Fluorodeoxyglucose F18; Humans; Medicare; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; United States	2023
Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2023, Volume: 27, Issue:2 Topics: CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2023
[Traumatic Neuroma Mimicking Lymph Node Metastasis of Pancreatic Neuroendocrine Neoplasms Developed after Pancreatoduodenectomy-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:13 Topics: Aged; Bile Ducts; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neuroendocrine Tumors; Neuroma; Pancreatic Neoplasms; Pancreaticoduodenectomy	2022
Added value of digital FDG-PET/CT in disease staging and restaging in patients with resectable or borderline resectable pancreatic cancer. Surgical oncology, 2023, Volume: 47 Topics: CA-19-9 Antigen; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies	2023
Rare Case of Phyllodes Tumor of Breast with Cardiac and Pancreatic Metastases: Findings on Journal of nuclear medicine technology, 2023, Volume: 51, Issue:2 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Phyllodes Tumor; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed	2023
Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review. Nuclear medicine communications, 2023, Jun-01, Volume: 44, Issue:6 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies	2023
Benign pancreatic lesion on 18F-FDG PET-MRI: A case report. Medicine, 2023, May-12, Volume: 102, Issue:19 Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2023
Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, Cancer imaging : the official publication of the International Cancer Imaging Society, 2023, May-22, Volume: 23, Issue:1 Topics: Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2023
Initial Evaluation of [ Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:8 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms	2023
A Case of Pancreatic Cancer With Rare Cutaneous and Muscle Metastases on 18 F-FDG PET/CT Imaging. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscles; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2023
18 F-fluorodeoxyglucose PET/computed tomography metabolic parameters and sarcopenia in pancreatic cancer. Nuclear medicine communications, 2023, 08-01, Volume: 44, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2023
Intraductal oncocytic papillary neoplasm of the pancreas: clinical and radiological features compared to those of intraductal papillary mucinous neoplasm. Abdominal radiology (New York), 2023, Volume: 48, Issue:8 Topics: CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma, Pancreatic Ductal; Cysts; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Pancreas; Pancreatic Neoplasms; Retrospective Studies	2023
Preoperative prediction of microvascular invasion and perineural invasion in pancreatic ductal adenocarcinoma with Clinical radiology, 2023, Volume: 78, Issue:9 Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies	2023
Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT. Clinical nuclear medicine, 2023, Sep-01, Volume: 48, Issue:9 Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2023
Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from Clinical radiology, 2023, Volume: 78, Issue:10 Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nomograms; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2023
68 Ga-PSMA PET/CT in Hepatic Metastasis From Pancreatic Neuroendocrine Tumor. Clinical nuclear medicine, 2023, Nov-01, Volume: 48, Issue:11 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2023
Comparison of early and late Scientific reports, 2023, 10-19, Volume: 13, Issue:1 Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cholestasis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines; Retrospective Studies; Tomography, X-Ray Computed	2023
[IPMC of the pancreas with enlarged para-aortic lymph nodes with a high accumulation of FDG-PET:a case report]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2019, Volume: 116, Issue:9 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Male; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy	2019
The value of Abdominal radiology (New York), 2019, Volume: 44, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Micrometastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity	2019
[Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2019, Oct-25, Volume: 36, Issue:5 Topics: Adenocarcinoma; Algorithms; Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography; Support Vector Machine	2019
Testicular Metastasis of Pancreatic Carcinoma on FDG-PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:1 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testicular Neoplasms	2020
Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor: Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging. Clinical nuclear medicine, 2020, Volume: 45, Issue:2 Topics: Corticotropin-Releasing Hormone; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Treatment Outcome	2020
Diagnostic and interventional imaging, 2019, Volume: 100, Issue:12 Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals	2019
Ovarian Metastasis as Initial Presentation of Pancreatic Carcinoma on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:4 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2020
Abdominal radiology (New York), 2020, Volume: 45, Issue:3 Topics: Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2020
Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals	2020
Imaging phenotype using European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Mutation; Pancreatic Neoplasms; Phenotype; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma. Pancreas, 2020, Volume: 49, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cohort Studies; Disease-Free Survival; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Outcome Assessment, Health Care; Pancreatic Neoplasms; Positron-Emission Tomography	2020
18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor. Clinical nuclear medicine, 2020, Volume: 45, Issue:5 Topics: Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2020
Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:5 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2020
Early recurrence detected by 18F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma. Medicine, 2020, Volume: 99, Issue:11 Topics: Adenocarcinoma; China; Female; Fluorodeoxyglucose F18; Humans; Male; Margins of Excision; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Analysis	2020
hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer. Cancer letters, 2020, 06-01, Volume: 479 Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Equilibrative Nucleoside Transporter 1; Fluorodeoxyglucose F18; Gemcitabine; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Pancreatic Neoplasms; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Xenograft Model Antitumor Assays	2020
Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma. Cancer research, 2020, 06-01, Volume: 80, Issue:11 Topics: Animals; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Electron Spin Resonance Spectroscopy; Fluorodeoxyglucose F18; Glucose; Glycolysis; Heterografts; Humans; Mice; Molecular Imaging; Oxygen; Pancreatic Neoplasms; Partial Pressure; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment	2020
Usefulness of Cancer medicine, 2020, Volume: 9, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden	2020
FDG PET/CT Imaging of Pancreatic Plasmacytoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:6 Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pancreatic Neoplasms; Plasmacytoma; Positron Emission Tomography Computed Tomography	2020
Combined 68Ga-DOTATOC and 18F-FDG PET Predicts a Double Component With Different Grade of a Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 1. Clinical nuclear medicine, 2020, Volume: 45, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis	2020
Simplified dual time point FDG-PET/computed tomography for determining dignity of pancreatic lesions. Nuclear medicine communications, 2020, Volume: 41, Issue:7 Topics: Adult; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography; Time Factors	2020
A case of alveolar rhabdomyosarcoma showing concurrent responsive bone marrow lesions and refractory pancreatic lesions to pazopanib monotherapy. Pediatric blood & cancer, 2020, Volume: 67, Issue:9 Topics: Adolescent; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Forkhead Box Protein O1; Humans; Indazoles; Oncogene Proteins, Fusion; Paired Box Transcription Factors; Pancreatic Neoplasms; PAX3 Transcription Factor; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma, Alveolar; Sulfonamides; Tumor Microenvironment; Zoledronic Acid	2020
Rare case of metastatic small cell carcinoma of the nasopharynx to the pancreas. BMJ case reports, 2020, Jun-09, Volume: 13, Issue:6 Topics: Carcinoma, Small Cell; Chemoradiotherapy; Cholecystectomy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasopharynx; Neoplasm Staging; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Splenectomy	2020
Primary Pancreatic Lymphoma on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2020
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment. Nuclear medicine communications, 2020, Volume: 41, Issue:9 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radioactive Tracers; Retrospective Studies; Risk Assessment; Young Adult	2020
Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Medicine, 2020, Aug-28, Volume: 99, Issue:35 Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies	2020
Pancreatic Schwannoma on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neurilemmoma; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2020
Preliminary evaluation of 18F-FDG-PET/MRI for differentiation of serous from nonserous pancreatic cystic neoplasms: a pilot study. Nuclear medicine communications, 2020, Volume: 41, Issue:12 Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography	2020
Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT. Nuclear medicine review. Central & Eastern Europe, 2020, Volume: 23, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Muscle, Skeletal; Pancreatic Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms	2020
Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer. Scientific reports, 2020, 10-12, Volume: 10, Issue:1 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Rate	2020
Preoperative carbohydrate antigen 19-9 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma. Journal of hepato-biliary-pancreatic sciences, 2022, Volume: 29, Issue:10 Topics: Adenocarcinoma; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2022
TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT. Oncology, 2021, Volume: 99, Issue:3 Topics: Aged; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Transketolase	2021
Editorial Comment: FDG PET/MRI and CT as Predictive Markers of Response of Borderline Resectable Pancreatic Cancer to Neoadjuvant Therapy. AJR. American journal of roentgenology, 2021, Volume: 217, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Tomography, X-Ray Computed	2021
Liver Abscess With High 18F-FDG Uptake and No 18F-Fluorothymidine Uptake. Clinical nuclear medicine, 2021, Apr-01, Volume: 46, Issue:4 Topics: Biological Transport; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Liver Abscess; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2021
Collision of Solid Pseudopapillary Tumor and Neuroendocrine Tumor of the Pancreas on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Apr-01, Volume: 46, Issue:4 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2021
18F-FDG PET/CT Imaging of Pancreatic and Adrenal Metastases in a Patient With Mesenchymal Chondrosarcoma. Clinical nuclear medicine, 2021, Mar-01, Volume: 46, Issue:3 Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Chondrosarcoma, Mesenchymal; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Young Adult	2021
Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study. Molecular imaging and biology, 2021, Volume: 23, Issue:3 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2021
Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma. Nuclear medicine communications, 2021, May-01, Volume: 42, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Apoptosis Regulatory Proteins; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Pancreatic Neoplasms; Phosphoric Monoester Hydrolases; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies	2021
Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases. Neuroendocrinology, 2022, Volume: 112, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Outcome and Process Assessment, Health Care; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2022
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases. Clinical nuclear medicine, 2021, Jul-01, Volume: 46, Issue:7 Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines	2021
Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021, Volume: 21, Issue:4 Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2021
Detection of Adult Pancreatoblastoma by 18F-FDG and 68Ga-DOTATATE PET/MR. Clinical nuclear medicine, 2021, Aug-01, Volume: 46, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Multimodal Imaging; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography	2021
Radiomics model of dual-time 2-[ European radiology, 2021, Volume: 31, Issue:9 Topics: Autoimmune Pancreatitis; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies	2021
Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer. BJS open, 2021, 03-05, Volume: 5, Issue:2 Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms	2021
Multiparameter Analysis Using Contrast media & molecular imaging, 2021, Volume: 2021 Topics: Adult; Cystadenoma, Mucinous; Cystadenoma, Serous; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Cyst; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior. Frontiers in endocrinology, 2021, Volume: 12 Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neck Dissection; Pancreatic Neoplasms; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Whole Body Imaging	2021
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. Clinical nuclear medicine, 2021, Sep-01, Volume: 46, Issue:9 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines	2021
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival. The British journal of surgery, 2021, 12-17, Volume: 109, Issue:1 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed	2021
Appendiceal Neuroendocrine Tumor Detected by 18F-FDG PET/CT. Clinical nuclear medicine, 2022, Jan-01, Volume: 47, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1. The Journal of clinical endocrinology and metabolism, 2017, 06-01, Volume: 102, Issue:6 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Ultrasonography	2017
FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2017, Volume: 43, Issue:6 Topics: Aged; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Tumor Burden	2017
Thymoma metastatic to liver and pancreas: case report and review of the literature. The Journal of international medical research, 2017, Volume: 45, Issue:2 Topics: Aged; Brachiocephalic Veins; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Neoadjuvant Therapy; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiotherapy, Adjuvant; Thymectomy; Thymus Neoplasms; Treatment Outcome; Vena Cava, Superior	2017
18F-FDG PET/CT in the Detection of Undifferentiated Carcinoma With Osteoclast-like Giant Cells of the Pancreas. Clinical nuclear medicine, 2017, Volume: 42, Issue:8 Topics: Carcinoma, Giant Cell; Fluorodeoxyglucose F18; Humans; Osteoclasts; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2017
Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma. Annals of nuclear medicine, 2017, Volume: 31, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2017
Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma. European journal of radiology, 2017, Volume: 94 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Tumor Burden	2017
The diagnostic utility of Merkel cell polyomavirus immunohistochemistry in a fine needle aspirate of metastatic Merkel cell carcinoma of unknown primary to the pancreas. Diagnostic cytopathology, 2018, Volume: 46, Issue:1 Topics: Adult; Antigens, Polyomavirus Transforming; Carcinoma, Merkel Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Male; Merkel cell polyomavirus; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms	2018
Pancreatoblastoma With Metastatic Retroperitoneal Lymph Node and PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:11 Topics: Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retroperitoneal Space; Ultrasonography	2017
Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma. Abdominal radiology (New York), 2018, Volume: 43, Issue:2 Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids	2018
SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018, Volume: 50, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis	2018
Uncommon Metastasis to the Pancreas From Adenocarcinoma of the Cervix Detected on Surveillance 18F-FDG PET/CT Imaging. Clinical nuclear medicine, 2017, Volume: 42, Issue:12 Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms	2017
Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies. Medical science monitor : international medical journal of experimental and clinical research, 2017, Oct-16, Volume: 23 Topics: Adenocarcinoma; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome	2017
Clinical Usefulness of The oncologist, 2018, Volume: 23, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate	2018
18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2018, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Survival Rate	2018
Focal Autoimmune Pancreatitis Mimicking Pancreatic Cancer on FDG PET/CT Imaging. Clinical nuclear medicine, 2018, Volume: 43, Issue:1 Topics: Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography	2018
A small pancreatic hamartoma with an obstruction of the main pancreatic duct and avid FDG uptake mimicking a malignant pancreatic tumor: a systematic case review. BMC gastroenterology, 2017, Dec-06, Volume: 17, Issue:1 Topics: Aged; Cholangiopancreatography, Endoscopic Retrograde; Constriction, Pathologic; Diagnosis, Differential; Endosonography; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Magnetic Resonance Imaging; Pancreatic Diseases; Pancreatic Ducts; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed	2017
Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [ Molecular imaging and biology, 2018, Volume: 20, Issue:4 Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Metformin; Mice, SCID; Pancreatic Neoplasms; Positron-Emission Tomography	2018
Pancreatic Malignancy or Not?: Role of 18F-FDG PET/CT in Solving the Diagnostic Dilemma and Evaluating Treatment Response. Clinical nuclear medicine, 2018, Volume: 43, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Treatment Outcome	2018
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer. Cell death & disease, 2018, 02-23, Volume: 9, Issue:3 Topics: Aerobiosis; Base Sequence; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Protein Stability; Signal Transduction; Survival Analysis; Transcription Factor 7-Like 2 Protein; Transcription, Genetic	2018
Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study. Scientific reports, 2018, 02-26, Volume: 8, Issue:1 Topics: Autoimmune Diseases; Case-Control Studies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Logistic Models; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography	2018
Is 18F-Fluorodeoxyglucose the Tracer of Choice for Functional Imaging of Neuroendocrine Tumors Grade 3? A Case Report. Pancreas, 2018, Volume: 47, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Stomach Neoplasms	2018
18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer. Japanese journal of clinical oncology, 2018, May-01, Volume: 48, Issue:5 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis	2018
ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer. Biochemical and biophysical research communications, 2018, 06-12, Volume: 500, Issue:4 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cricetulus; ErbB Receptors; Feedback, Physiological; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Reactive Oxygen Species; Signal Transduction	2018
PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms. BMC cancer, 2018, May-04, Volume: 18, Issue:1 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Neoplasms, Second Primary; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis	2018
FDG-PET CT in the evaluation of primary and secondary pancreatic malignancies. Pediatric blood & cancer, 2018, Volume: 65, Issue:10 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult	2018
Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer. Nuclear medicine communications, 2018, Volume: 39, Issue:8 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies	2018
Quantifying the robustness of [ Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2018, Volume: 49 Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2018
Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival. Nuclear medicine communications, 2018, Volume: 39, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2018
[Prognostic value of PET/CT in pancreatic cancer]. Revista medica de Chile, 2018, Volume: 146, Issue:4 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Time Factors; Tumor Burden	2018
Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer. Abdominal radiology (New York), 2018, Volume: 43, Issue:12 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Kaplan-Meier Estimate; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies	2018
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI. AJR. American journal of roentgenology, 2018, Volume: 211, Issue:5 Topics: Aged; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Tumor Burden	2018
Prognostic value of CT attenuation and FDG uptake of adipose tissue in patients with pancreatic adenocarcinoma. Clinical radiology, 2018, Volume: 73, Issue:12 Topics: Adenocarcinoma; Adipose Tissue; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2018
A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018, Volume: 129, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-19-9 Antigen; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nomograms; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome	2018
Recurrence of Extramedullary Plasmacytomas Involving Lymph Nodes and Pancreas Revealed by 68Ga-DOTATATE and 18F-FDG PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Lymph Nodes; Male; Neuroendocrine Tumors; Nose Neoplasms; Organometallic Compounds; Pancreatic Neoplasms; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms	2018
Occult Giant Cell Arteritis Concurrent With Pancreatic Carcinoma Revealed by 18F-FDG PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Incidental Findings; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceedings of the National Academy of Sciences of the United States of America, 2018, 11-06, Volume: 115, Issue:45 Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Coordination Complexes; Dendrimers; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms	2018
Significance of Annals of surgical oncology, 2019, Volume: 26, Issue:2 Topics: Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tumor Burden	2019
Preoperative Metabolic Tumor Volume Gut and liver, 2019, 05-15, Volume: 13, Issue:3 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Phenotype; Positron-Emission Tomography; Preoperative Period; Prognosis; Transcriptome; Tumor Burden	2019
Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma. PloS one, 2019, Volume: 14, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome	2019
Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging. Clinical nuclear medicine, 2019, Volume: 44, Issue:5 Topics: Adenocarcinoma of Lung; Adult; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Prognostic values of 18F-FDG PET/CT metabolic parameters and clinical figures in locally advanced pancreatic cancer underwent chemotherapy combined with stereotactic body radiation therapy. Medicine, 2019, Volume: 98, Issue:13 Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Survival Rate; Treatment Outcome; Tumor Burden	2019
The clinical utility of phase-based respiratory gated PET imaging based on visual feedback with a head-mounted display system. The British journal of radiology, 2019, Volume: 92, Issue:1098 Topics: Aged; Biliary Tract Neoplasms; Equipment Design; Feedback, Sensory; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; User-Computer Interface	2019
Sister Mary Joseph Nodule in Advanced Pancreatic Adenocarcinoma Identified on Journal of nuclear medicine technology, 2019, Volume: 47, Issue:4 Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Sister Mary Joseph's Nodule	2019
The target therapeutic effect of functionalized graphene oxide nanoparticles graphene oxide-polyethylene glycol-folic acid-1-pyrenemethylamine hydrochloride-mediated RNA interference of HIF-1α gene in human pancreatic cancer cells. Journal of biomaterials applications, 2019, Volume: 34, Issue:2 Topics: Animals; Cell Line, Tumor; Drug Carriers; Fluorodeoxyglucose F18; Folic Acid; Gene Knockdown Techniques; Genetic Therapy; Glucose Transporter Type 1; Graphite; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Methylamines; Mice, Nude; Molecular Targeted Therapy; Nanoparticles; Neoplasms, Experimental; Pancreatic Neoplasms; Polyethylene Glycols; Pyrenes; RNA Interference; RNA, Messenger; Transfection	2019
Incidental Detection of Adenocarcinoma in the Neck of the Pancreas by FDG PET Imaging When a Cystic Lesion in the Body of Pancreas Was Evaluated. Clinical nuclear medicine, 2019, Volume: 44, Issue:11 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2019
Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:1 Topics: Adult; Aged; CA-19-9 Antigen; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Treatment Outcome	2020
Adult Pancreatoblastoma With Liver Metastasis Diagnosed by 18F-FDG PET/CT and 2 Years' Postoperative Follow-up. Clinical nuclear medicine, 2020, Volume: 45, Issue:1 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Period	2020
18F-FDG PET/MR in an Atypical Pediatric Solid Pseudopapillary Pancreatic Tumor. Clinical nuclear medicine, 2019, Volume: 44, Issue:9 Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography	2019
Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:12 Topics: Biomarkers, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results	2019
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. Nuclear medicine communications, 2019, Volume: 40, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Time Factors	2019
Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis. Nature reviews. Gastroenterology & hepatology, 2013, Volume: 10, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Decision Making; Diagnostic Imaging; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals	2013
Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis. Clinical nuclear medicine, 2013, Volume: 38, Issue:6 Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Pancreatitis; Radiography; Radionuclide Imaging	2013
FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome. Clinical nuclear medicine, 2013, Volume: 38, Issue:7 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; von Hippel-Lindau Disease	2013
A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:7 Topics: ACTH Syndrome, Ectopic; Adult; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation. Nuclear medicine communications, 2013, Volume: 34, Issue:6 Topics: Adolescent; Adult; Aged; Cell Proliferation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2013
Education and imaging. Hepatobiliary and pancreatic: intrahepatic biliary cystadenocarcinoma. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cystadenocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography	2013
The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT. Annals of nuclear medicine, 2013, Volume: 27, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2013
Synchronous quadruple primary tumors of thyroid, breast, pancreas, and stomach: a case report. Anticancer research, 2013, Volume: 33, Issue:5 Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed	2013
Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals	2014
18F-FDG uptake in intraductal tubulopapillary neoplasm of the pancreas. Clinical nuclear medicine, 2014, Volume: 39, Issue:4 Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Positron-Emission Tomography	2014
Topographic diagnosis: respective roles of morphological and functional imaging. Annales d'endocrinologie, 2013, Volume: 74, Issue:3 Topics: 5-Hydroxytryptophan; Anatomy, Cross-Sectional; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemia; Imaging, Three-Dimensional; Insulinoma; Magnetic Resonance Imaging; Pancreatic Neoplasms; Practice Guidelines as Topic; Receptors, Glucagon; Receptors, Somatostatin	2013
Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma. JOP : Journal of the pancreas, 2013, Jul-11, Volume: 14, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2013
Are Radiation Therapy Oncology Group Para-aortic Contouring Guidelines for Pancreatic Neoplasm applicable to other malignancies--assessment of nodal distribution in gynecological malignancies. International journal of radiation oncology, biology, physics, 2013, Sep-01, Volume: 87, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Aorta; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Guideline Adherence; Humans; Lumbar Vertebrae; Lymph Nodes; Lymphatic Metastasis; Lymphography; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Psoas Muscles; Radiation Oncology; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Renal Artery; Renal Veins; Retrospective Studies; Tomography, X-Ray Computed; Vena Cava, Inferior	2013
Unsuspected fluorodeoxyglucose positron emission tomography (FDG-PET)-positive pancreatic lesions: prevalence and significance. Pancreas, 2013, Volume: 42, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Predictive value of maximum standardized uptake value (SUVmax) on 18F-FDG PET/CT in patients with locally advanced or metastatic pancreatic cancer. Clinical nuclear medicine, 2013, Volume: 38, Issue:10 Topics: Aged; Blood Glucose; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed; Tumor Burden	2013
Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdominal imaging, 2014, Volume: 39, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2014
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer. Yonsei medical journal, 2013, Volume: 54, Issue:6 Topics: Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies	2013
Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary? Clinical nuclear medicine, 2014, Volume: 39, Issue:1 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed	2014
FDG-PET/CT-based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy. Cancer imaging : the official publication of the International Cancer Imaging Society, 2013, Oct-04, Volume: 13, Issue:3 Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma. European journal of radiology, 2014, Volume: 83, Issue:1 Topics: Adult; Aged; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT". Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Reply: Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT". Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Usefulness of 18F-fluorodeoxyglucose positron emission tomography as predictor of distant metastasis in preoperative carbon-ion radiotherapy for pancreatic cancer. Anticancer research, 2013, Volume: 33, Issue:12 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Survival Analysis	2013
Multimodal image driven patient specific tumor growth modeling. Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention, 2013, Volume: 16, Issue:Pt 3 Topics: Algorithms; Cell Proliferation; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Biological; Multimodal Imaging; Pancreatic Neoplasms; Patient-Centered Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden	2013
Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2014
Positron emission tomography imaging of pancreatic cancer. JOP : Journal of the pancreas, 2014, Mar-10, Volume: 15, Issue:2 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis	2014
Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer. Annals of nuclear medicine, 2014, Volume: 28, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden	2014
Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions. Journal of the American College of Surgeons, 2014, Volume: 218, Issue:5 Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; von Hippel-Lindau Disease; Young Adult	2014
Comparing the performance of visual estimation and standard uptake value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. The journal of medical investigation : JMI, 2014, Volume: 61, Issue:1-2 Topics: Adenoma; Adult; Aged; Cystadenoma, Serous; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2014
The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography	2014
Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. International journal of radiation oncology, biology, physics, 2014, Jul-01, Volume: 89, Issue:3 Topics: Contrast Media; Duodenum; Fluorodeoxyglucose F18; Humans; Kidney; Liver; Magnetic Resonance Imaging; Multimodal Imaging; Organ Size; Organs at Risk; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Stomach; Time Factors; Tomography, X-Ray Computed; Tumor Burden	2014
18F-FDG PET imaging in a patient with late omental infarction after treatment of pancreatic adenocarcinoma. Clinical nuclear medicine, 2014, Volume: 39, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Humans; Infarction; Male; Omentum; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time. Clinical nuclear medicine, 2015, Volume: 40, Issue:1 Topics: Adult; Aged; Body Weight; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Tomography, X-Ray Computed	2015
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis	2014
Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2014, Volume: 18, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer. Radiation oncology (London, England), 2014, Jun-24, Volume: 9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed	2014
Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy. International journal of radiation oncology, biology, physics, 2014, Sep-01, Volume: 90, Issue:1 Topics: Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2014
Dual-phase 18F-FDG PET/CT imaging in the characterization of pancreatic lesions: does it offer prognostic information? Nuclear medicine communications, 2014, Volume: 35, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis	2014
Staging accuracy of pancreatic cancer: comparison between non-contrast-enhanced and contrast-enhanced PET/CT. European journal of radiology, 2014, Volume: 83, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors. International journal of oncology, 2014, Volume: 45, Issue:4 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2014
18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer. Nuclear medicine communications, 2014, Volume: 35, Issue:11 Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Survival Analysis; Tomography, X-Ray Computed	2014
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas. Pancreas, 2014, Volume: 43, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; ErbB Receptors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Proteins; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Survival Analysis; Tomography, X-Ray Computed	2014
Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Annals of surgical oncology, 2015, Volume: 22, Issue:2 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; ROC Curve; Survival Analysis	2015
Primary pancreatic choriocarcinoma revealed on FDG PET/CT. Clinical nuclear medicine, 2015, Volume: 40, Issue:1 Topics: Adult; Choriocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2015
Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Acta radiologica (Stockholm, Sweden : 1987), 2015, Volume: 56, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed	2015
High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:11 Topics: Aged; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Probability; Prognosis; Proportional Hazards Models; Radionuclide Imaging; ROC Curve; Stomach Neoplasms; Treatment Outcome	2014
The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors. Neuroendocrinology, 2014, Volume: 100, Issue:4 Topics: Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors. Surgery, 2015, Volume: 157, Issue:2 Topics: Adult; Aged; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; World Health Organization	2015
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:11 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed	2014
Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy. Yonsei medical journal, 2014, Volume: 55, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden	2014
F-18 FDG hypermetabolism in mass-forming focal pancreatitis and old hepatic schistosomiasis with granulomatous inflammation misdiagnosed by PET/CT imaging. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:9 Topics: Biopsy; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Granuloma; Humans; Liver Diseases, Parasitic; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Schistosomiasis; Tomography, X-Ray Computed; Whole Body Imaging	2014
Can PET/CT guide the personalized treatment of patients with gastroenteropancreatic neuroendocrine neoplasms? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed	2014
Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic ductal adenocarcinoma patients with diabetes. American journal of surgery, 2015, Volume: 209, Issue:4 Topics: Aged; Carcinoma, Pancreatic Ductal; Diabetes Complications; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2015
Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer. Cancer letters, 2015, May-01, Volume: 360, Issue:2 Topics: Biomarkers, Tumor; CA-125 Antigen; CA-19-9 Antigen; Carbohydrate Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Tumor Burden	2015
Multiple Pathologies Seen on a Single Contrast-Enhanced 18F-FDG PET/CT: Reiteration of Lessons Previously Learned. Clinical nuclear medicine, 2015, Volume: 40, Issue:9 Topics: Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphadenitis; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma. Hepato-gastroenterology, 2014, Volume: 61, Issue:135 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; China; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies	2014
A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: stimulation of the Warburg effect in AsPC-1 cells. Nuclear medicine and biology, 2015, Volume: 42, Issue:5 Topics: Ascites; Biological Transport; Cell Line, Tumor; Early Detection of Cancer; Fluorodeoxyglucose F18; Glycolysis; Hexoses; Humans; Neoplasm Metastasis; Pancreatic Neoplasms; Phosphofructokinase-1; Positron-Emission Tomography	2015
(18)F-FDG-PET/CT findings in pancreatic metastasis. La Radiologia medica, 2015, Volume: 120, Issue:10 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2015
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer. Annals of nuclear medicine, 2015, Volume: 29, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult	2015
Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT). Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms	2015
Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors. Pancreas, 2015, Volume: 44, Issue:4 Topics: Adult; Aged; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden	2015
18F-FDG activitiy PET/CT and CA-19.9 levels for the prediction of histopathological features and localization of peri- ampullary tumors. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2015, Volume: 26, Issue:2 Topics: Adult; Aged; Ampulla of Vater; CA-19-9 Antigen; Common Bile Duct Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed	2015
The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988. Cancer biotherapy & radiopharmaceuticals, 2015, Volume: 30, Issue:4 Topics: Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Genetic Vectors; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lentivirus; Pancreatic Neoplasms; RNA Interference; RNA, Messenger; Transfection	2015
Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible? The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2017, Volume: 61, Issue:4 Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Heterografts; Insulinoma; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Tetrabenazine; Vesicular Monoamine Transport Proteins	2017
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging. AJR. American journal of roentgenology, 2015, Volume: 204, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden	2015
Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT). Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms	2015
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB : the official journal of the International Hepato Pancreato Biliary Association, 2015, Volume: 17, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Queensland; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer. The British journal of radiology, 2015, Volume: 88, Issue:1051 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Organs at Risk; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden	2015
[Modern technologies and diagnostics in treatment of neuroendocrine tumors of the pancreas]. Vestnik khirurgii imeni I. I. Grekova, 2015, Volume: 174, Issue:1 Topics: Adult; Angiography; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroendocrine Tumors; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed	2015
Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Adult; Aged; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer. Clinical nuclear medicine, 2015, Volume: 40, Issue:11 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Cancer research, 2015, Aug-15, Volume: 75, Issue:16 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Carbon-13 Magnetic Resonance Spectroscopy; Cell Proliferation; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactates; Male; Mice, Nude; Mutation; Naphthalenes; Pancreatic Neoplasms; Phosphoric Monoester Hydrolases; Positron-Emission Tomography; Pyruvic Acid; Reverse Transcriptase Polymerase Chain Reaction; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2015
A case of pancreatic schwannoma - The features in imaging studies compared with its pathological findings: Report of a case. Clinical journal of gastroenterology, 2014, Volume: 7, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neurilemmoma; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Pancreatic Tumor Growth Prediction with Multiplicative Growth and Image-Derived Motion. Information processing in medical imaging : proceedings of the ... conference, 2015, Volume: 24 Topics: Algorithms; Artificial Intelligence; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Motion; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Tumor Burden	2015
Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer. Abdominal imaging, 2015, Volume: 40, Issue:8 Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2015
In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography. Oncotarget, 2015, Nov-10, Volume: 6, Issue:35 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, ErbB-3; Time Factors; Tumor Burden; X-Ray Microtomography; Xenograft Model Antitumor Assays	2015
18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction. Nuclear medicine communications, 2016, Volume: 37, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2016
Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology, 2015, Volume: 277, Issue:3 Topics: Adenocarcinoma; Biomarkers; Blood Proteins; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Cost-Benefit Analysis; Diagnostic Imaging; DNA Methylation; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; MicroRNAs; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:3 Topics: Aged; Aged, 80 and over; Algorithms; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes	2016
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction. Physics in medicine and biology, 2016, Jan-07, Volume: 61, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Functional imaging of interstitial brachytherapy in pancreatic carcinoma xenografts using spectral CT: how does iodine concentration correlate with standardized uptake value of (18)FDG-PET-CT? The British journal of radiology, 2016, Volume: 89, Issue:1058 Topics: Animals; Brachytherapy; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Transplantation, Heterologous	2016
Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma. Pancreas, 2016, Volume: 45, Issue:7 Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; RNA, Messenger; Survival Analysis	2016
The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients. HPB : the official journal of the International Hepato Pancreato Biliary Association, 2016, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2016
[Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Showing High Accumulation of 18F-Fluorodeoxyglucose (FDG)--A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Adenocarcinoma, Mucinous; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Treatment Outcome	2015
Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review. Nuclear medicine review. Central & Eastern Europe, 2016, Volume: 19, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions. Clinical nuclear medicine, 2016, Volume: 41, Issue:5 Topics: Adult; Aged; Biliary Tract Neoplasms; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2016
Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer. Medicine, 2016, Volume: 95, Issue:9 Topics: Aged; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2016
Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer. Gastrointestinal endoscopy, 2016, Volume: 84, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Aorta; Bile Duct Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Common Bile Duct Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals	2016
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 08-01, Volume: 22, Issue:15 Topics: Animals; Carrier Proteins; Cell Line, Tumor; Disease Models, Animal; F-Box-WD Repeat-Containing Protein 7; Female; Fluorodeoxyglucose F18; Gene Expression; Glucose; Heterografts; Humans; Mice; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Proteins; Proto-Oncogene Proteins c-myc	2016
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Taiwan; Young Adult	2016
Predictive prognostic value of local and distant recurrence of F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to World Health Organization classifications (2004, 2010). Case series study. International journal of surgery (London, England), 2016, Volume: 29 Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mitotic Index; Neoplasm Grading; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; World Health Organization	2016
Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using (18)F-FDG PET/CT for Monitoring Treatment Response. Cancer biotherapy & radiopharmaceuticals, 2016, Volume: 31, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Colchicine; Deoxycytidine; Drug Synergism; Female; Fluorodeoxyglucose F18; Gemcitabine; High-Throughput Screening Assays; Humans; Immunoenzyme Techniques; Liliaceae; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Plant Extracts; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seeds; Toxicity Tests, Acute; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2016
Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer. Medicine, 2016, Volume: 95, Issue:17 Topics: Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Gene Silencing; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Smad4 Protein; Statistics as Topic; Survival Analysis; Tomography, X-Ray Computed	2016
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Medicine, 2016, Volume: 95, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2016
Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:8 Topics: CA-19-9 Antigen; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody. Oncotarget, 2016, Jun-21, Volume: 7, Issue:25 Topics: Animals; Antibodies, Monoclonal; Body Weight; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Integrin alpha6beta4; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes	2016
THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER. Georgian medical news, 2016, Issue:253 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2016
Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 120, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Respiratory Mechanics; Tumor Burden	2016
Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International journal of radiation oncology, biology, physics, 2016, 09-01, Volume: 96, Issue:1 Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Treatment Outcome	2016
Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases. Clinical nuclear medicine, 2016, Volume: 41, Issue:11 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Octreotide; Organometallic Compounds; Ovarian Neoplasms; Pancreatic Neoplasms; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen	2016
High Uptake of FDG Along a Biliary Stent. Clinical nuclear medicine, 2016, Volume: 41, Issue:11 Topics: Aged; Biliary Tract; Biliary Tract Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stents	2016
The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients. European journal of radiology, 2016, Volume: 85, Issue:10 Topics: Aged; Aged, 80 and over; Animals; Cells, Cultured; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Japan; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; TOR Serine-Threonine Kinases	2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals	2017
Utility of 18 fludeoxyglucose in preoperative positon-emission tomography-computed tomography (PET-CT) in the early diagnosis of exocrine pancreatic cancer: A study of 139 resected cases. Cirugia espanola, 2016, Volume: 94, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreas, Exocrine; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals	2016
Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcino European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1 Topics: Abdominal Fat; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Subcutaneous Fat; Survival Rate	2017
Intraductal Papillary Mucinous Neoplasm of the Pancreas With High Malignant Potential on FDG PET/MRI. Clinical nuclear medicine, 2016, Volume: 41, Issue:12 Topics: Bile Duct Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2017
Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions. Pancreas, 2017, Volume: 46, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity	2017
Granulocytic sarcoma of the pancreas on 18F-FDG PET/CT: A case report. Medicine, 2016, Volume: 95, Issue:49 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leukemia, Myeloid, Acute; Male; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Salvage Therapy; Sarcoma, Myeloid; Stem Cell Transplantation; Young Adult	2016
Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor. Clinical nuclear medicine, 2017, Volume: 42, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma. Journal of hepato-biliary-pancreatic sciences, 2017, Volume: 24, Issue:3 Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2017
Adenosquamous Carcinoma of the Pancreas Demonstrated on 18F-FDG PET/CT Imaging. Clinical nuclear medicine, 2017, Volume: 42, Issue:3 Topics: Aged; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:3 Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer. Annals of surgical oncology, 2017, Volume: 24, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate	2017
Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer. PloS one, 2017, Volume: 12, Issue:2 Topics: Aged; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2017
Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT. Nuclear medicine communications, 2017, Volume: 38, Issue:4 Topics: Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2017
Preventing pancreatic fistula after distal pancreatectomy: An invagination method. World journal of gastroenterology, 2017, Feb-28, Volume: 23, Issue:8 Topics: Drainage; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreas; Pancreatectomy; Pancreatic Fistula; Pancreatic Juice; Pancreatic Neoplasms; Positron-Emission Tomography; Postoperative Period; Suture Techniques; Tomography, X-Ray Computed; Treatment Outcome	2017
Surgical outcome of solid pseudopapillary tumor of the pancreas. Journal of hepato-biliary-pancreatic surgery, 2008, Volume: 15, Issue:3 Topics: Adolescent; Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Radionuclide Imaging	2008
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Annals of surgical oncology, 2008, Volume: 15, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients. Journal of gastrointestinal and liver diseases : JGLD, 2008, Volume: 17, Issue:2 Topics: Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results. Journal of experimental & clinical cancer research : CR, 2008, Jun-10, Volume: 27 Topics: Adenocarcinoma, Mucinous; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2008
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:8 Topics: Animals; Cell Line, Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Magnetic Resonance Imaging; Mice; Mice, SCID; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Polymerase Chain Reaction; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous	2008
Whipple's procedure in a renal transplant recipient with polycystic liver disease. JOP : Journal of the pancreas, 2008, Jul-10, Volume: 9, Issue:4 Topics: Adenocarcinoma; Aged; Cholangiopancreatography, Endoscopic Retrograde; Cysts; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Liver Diseases; Pancreatic Neoplasms; Pancreaticoduodenectomy; Polycystic Kidney Diseases; Positron-Emission Tomography	2008
Inguino-scrotal herniation of urinary bladder diverticulum in a patient with pancreatic carcinoma: a potential pitfall in whole-body 18F-FDG PET-CT. Nuklearmedizin. Nuclear medicine, 2008, Volume: 47, Issue:4 Topics: Aged; Diverticulum; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Diseases	2008
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis. Seminars in ultrasound, CT, and MR, 2008, Volume: 29, Issue:4 Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed	2008
[18F]FDG PET/CT in pancreatic neuroendocrine tumours associated with von Hippel Lindau Syndrome. Clinical endocrinology, 2009, Volume: 70, Issue:4 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; von Hippel-Lindau Disease	2009
F-18 fluorodeoxyglucose uptake in a solid pseudopapillary tumor of the pancreas mimicking malignancy. Clinical nuclear medicine, 2008, Volume: 33, Issue:11 Topics: Adenocarcinoma, Papillary; Adolescent; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2008
[Role of 18F-FDG PET scan in the differential diagnosis of large pancreatic masses]. Voprosy onkologii, 2008, Volume: 54, Issue:4 Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals	2008
Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. Journal of hepato-biliary-pancreatic surgery, 2008, Volume: 15, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome	2008
18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:12 Topics: Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2008
The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer research, 2009, Feb-01, Volume: 69, Issue:3 Topics: Adenocarcinoma; Animals; Cell Growth Processes; Cell Hypoxia; Connective Tissue Growth Factor; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Small Interfering; Transfection; Transplantation, Heterologous	2009
Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a case. Surgery today, 2009, Volume: 39, Issue:2 Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals	2009
Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Annals of nuclear medicine, 2009, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed	2009
Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors. Nuclear medicine communications, 2009, Volume: 30, Issue:5 Topics: Adult; Aged; Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inhalation; Lung Neoplasms; Male; Middle Aged; Movement; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Two cases of 18 F-FDG PET/CT findings in acinar cell carcinoma of the pancreas. Clinical nuclear medicine, 2009, Volume: 34, Issue:4 Topics: Aged; Carcinoma, Acinar Cell; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:5 Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Modalities for evaluating chemotherapeutic efficacy and survival time in patients with advanced pancreatic cancer: comparison between FDG-PET, CT, and serum tumor markers. Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Survival Rate; Tomography, X-Ray Computed	2009
Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR. American journal of roentgenology, 2009, Volume: 193, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Salivary Glands; Tissue Distribution; Tomography, X-Ray Computed; Young Adult	2009
A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Annals of surgery, 2009, Volume: 250, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Magnetic Resonance; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed	2009
Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG. Nuclear medicine communications, 2009, Volume: 30, Issue:12 Topics: Acetates; Adenocarcinoma; Animals; Carbon; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Isotope Labeling; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals	2009
Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Sep-01, Volume: 15, Issue:17 Topics: Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Regional Blood Flow	2009
Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? Journal of hepato-biliary-pancreatic sciences, 2010, Volume: 17, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2010
Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2010, Volume: 14, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed	2010
68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG. Molecular imaging and biology, 2010, Volume: 12, Issue:3 Topics: Animals; Autoradiography; Cell Line, Tumor; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Humans; Immunohistochemistry; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Rats; Tissue Distribution	2010
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. Molecular imaging and biology, 2010, Volume: 12, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2010
[Clinical usefulness of FDG-PET for pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2009
Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma. Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:1 Topics: Adult; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mutation; Pancreatic Neoplasms; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome	2010
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. International journal of radiation oncology, biology, physics, 2010, Aug-01, Volume: 77, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; CA-19-9 Antigen; Deoxycytidine; Disease-Free Survival; Fluorodeoxyglucose F18; Gemcitabine; Humans; Middle Aged; Multivariate Analysis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Retrospective Studies	2010
Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports. JOP : Journal of the pancreas, 2010, Jan-08, Volume: 11, Issue:1 Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Radionuclide Imaging	2010
Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study. JOP : Journal of the pancreas, 2010, Jan-08, Volume: 11, Issue:1 Topics: Aged; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pancreatic Neoplasms; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Ultrasonography	2010
PET and PET/CT for pancreatic malignancies. Surgical oncology clinics of North America, 2010, Volume: 19, Issue:2 Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
F-18 FDG PET/CT imaging of multifocal extramedullary pancreatic myeloma. Clinical nuclear medicine, 2010, Volume: 35, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. International journal of clinical oncology, 2010, Volume: 15, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Japan; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT. Nuklearmedizin. Nuclear medicine, 2010, Volume: 49, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Body Size; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
Role of glucose metabolism and cellularity for tumor malignancy evaluation using FDG-PET/CT and MRI. Nuclear medicine communications, 2010, Volume: 31, Issue:6 Topics: Aged; Aged, 80 and over; Biological Transport; Diffusion; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed	2010
Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2010, Volume: 14, Issue:7 Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
18 F-FDG PET/CT influences management in patients with known or suspected pancreatic cancer. Internal medicine journal, 2011, Volume: 41, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:10 Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases	2010
Solitary fibrous tumor of the pancreas. Japanese journal of radiology, 2010, Volume: 28, Issue:6 Topics: Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Middle Aged; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Solitary Fibrous Tumors; Tomography, X-Ray Computed; Ultrasonography	2010
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncology reports, 2010, Volume: 24, Issue:3 Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2010
[A case of pancreatic neuroendocrine tumor with multiple hepatic metastasis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 55, Issue:5 Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
A pancreatic mass presented with multiple hot spots in the subcutaneous fat layer on positron emission tomography. Acinar cell carcinoma with multiple fat necrosis. Gastroenterology, 2010, Volume: 139, Issue:4 Topics: Carcinoma, Acinar Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Subcutaneous Fat; Tomography, X-Ray Computed	2010
The utility of F-18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical nuclear medicine, 2010, Volume: 35, Issue:10 Topics: Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2010
Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin. Journal of clinical gastroenterology, 2011, Volume: 45, Issue:1 Topics: Biopsy; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography	2011
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection. International journal of clinical oncology, 2011, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Period	2011
[Benefit of PET/CT in the preoperative staging in pancreatic carcinomas]. Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti, 2010, Volume: 89, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2010
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Chi-Square Distribution; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Switzerland; Tomography, X-Ray Computed; Young Adult	2011
F-18 FDG accumulation in mucinous cystic neoplasm of pancreas. Clinical nuclear medicine, 2011, Volume: 36, Issue:1 Topics: Adult; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radionuclide Imaging; Tomography, X-Ray Computed	2011
Imaging diagnosis of post-ERCP focal pancreatitis mimicking pancreatic carcinoma by follow-up F-18 FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:1 Topics: Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Tumor-to-tumor metastasis: report of a case of renal cell carcinoma metastasizing to a pancreatic endocrine neoplasm. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Apr-10, Volume: 29, Issue:11 Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Tomography, X-Ray Computed	2011
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World journal of gastroenterology, 2011, Jan-14, Volume: 17, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
FDG PET/CT features of ovarian metastasis. Clinical radiology, 2011, Volume: 66, Issue:3 Topics: Adult; Breast Neoplasms; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms	2011
Pancreatic and hepatobiliary cancers. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2011
18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT. International journal of clinical oncology, 2011, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiography; Treatment Outcome	2011
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer. Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:2 Topics: Adenocarcinoma; Animals; Carcinoma in Situ; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Genetic Engineering; Glucose; Glucose Transporter Type 2; Humans; Mice; Mice, Transgenic; Pancreatic Neoplasms; Positron-Emission Tomography; Precancerous Conditions	2011
18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed? Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:4 Topics: Biopsy; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Research Design; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET. Clinical nuclear medicine, 2011, Volume: 36, Issue:5 Topics: Adult; Aged; Biological Transport; Blood Glucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed	2011
Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues. The oncologist, 2011, Volume: 16, Issue:6 Topics: Administration, Oral; Aged; Antineoplastic Agents; Blood Glucose; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Hypoglycemia; Insulin; Insulin Secretion; Insulinoma; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases	2011
Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer. American journal of clinical oncology, 2011, Volume: 34, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2011
(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Molecular imaging and biology, 2012, Volume: 14, Issue:2 Topics: Adenosine Triphosphate; Animals; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Basigin; Cell Death; Cell Line, Tumor; Contrast Media; Deoxycytidine; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Injections, Intravenous; Mice; Mice, SCID; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Xenograft Model Antitumor Assays	2012
Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Leucovorin; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tegafur; Tomography, X-Ray Computed; Uracil	2011
Pancreatic metastasis detected by F-18 FDG PET/CT in a patient with breast cancer. Clinical nuclear medicine, 2011, Volume: 36, Issue:6 Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Negative predictive value of positron emission tomography/computed tomography in patients with a clinical suspicion of pancreatic cancer. Pancreas, 2011, Volume: 40, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Biopsy, Fine-Needle; Cohort Studies; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2011
FDG PET/CT demonstration of pancreatic metastasis from prostate cancer. Clinical nuclear medicine, 2011, Volume: 36, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2011
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC gastroenterology, 2011, Nov-10, Volume: 11 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Annals of surgery, 2011, Volume: 254, Issue:6 Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Fluorodeoxyglucose F18; Guideline Adherence; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multidetector Computed Tomography; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. Molecular cancer therapeutics, 2012, Volume: 11, Issue:2 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Basigin; Carbocyanines; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, SCID; Microscopy, Fluorescence; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays	2012
MR imaging versus PET/CT for evaluation of pancreatic lesions. European journal of radiology, 2012, Volume: 81, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Variation; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: characteristic features on computed tomography. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36, Issue:3 Topics: Fluorodeoxyglucose F18; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Radiation oncology (London, England), 2012, Mar-19, Volume: 7 Topics: Adult; Aged; Area Under Curve; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; ROC Curve; Tomography, X-Ray Computed; Tumor Burden	2012
In vivo SPECT imaging with 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:5 Topics: Animals; Autoradiography; Cricetinae; Disease Models, Animal; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Inflammation; Mice; Nitrosamines; Organometallic Compounds; Pancreatic Neoplasms; Peptides, Cyclic; Tomography, Emission-Computed, Single-Photon	2012
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours. ANZ journal of surgery, 2012, Volume: 82, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cystadenoma, Serous; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
F-18 FDG PET/CT and Tc-99m sulfur colloid SPECT imaging in the diagnosis and treatment of a case of dual solitary fibrous tumors of the retroperitoneum and pancreas. Journal of radiology case reports, 2012, Volume: 6, Issue:3 Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Solitary Fibrous Tumors; Technetium Tc 99m Sulfur Colloid; Tomography, X-Ray Computed; Tongue Neoplasms	2012
Metastatic embryonal rhabdomyosarcoma to the pancreas presenting as acute pancreatitis detected by FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:7 Topics: Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Rhabdomyosarcoma, Embryonal; Tomography, X-Ray Computed	2012
The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer. Pancreas, 2012, Volume: 41, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2012
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Pancreas, 2013, Volume: 42, Issue:1 Topics: Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging	2013
Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting the pathologic response to preoperative chemoradiation therapy in patients with resectable T3 pancreatic cancer. World journal of surgery, 2013, Volume: 37, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior. Clinical nuclear medicine, 2013, Volume: 38, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Invasiveness; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT. Endocrine, 2013, Volume: 43, Issue:3 Topics: Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Peptides, Cyclic; Radionuclide Imaging; Somatostatin; Treatment Outcome	2013
Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Diagnosis, Differential; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; India; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed	2013
FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation. Clinical nuclear medicine, 2013, Volume: 38, Issue:3 Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2013
Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Annals of surgical oncology, 2002, Volume: 9, Issue:8 Topics: Adenocarcinoma; Ampulla of Vater; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	2002
[18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors]. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:10 Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:2 Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Glioblastoma; Humans; Macrophages; Monocytes; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tumor Cells, Cultured	2003
Pancreatic cancer: preliminary experience with sodium iodide fluorodeoxyglucose positron emission tomography in Australia. Australasian radiology, 2003, Volume: 47, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Iodide; Tomography, Emission-Computed	2003
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clinical nuclear medicine, 2003, Volume: 28, Issue:3 Topics: Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Catheter Ablation; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting	2003
Intraductal oncocytic papillary neoplasm of the pancreas shows strong positivity on FDG-PET. International journal of gastrointestinal cancer, 2002, Volume: 32, Issue:1 Topics: Adenocarcinoma, Papillary; Aged; Cholangiopancreatography, Endoscopic Retrograde; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatectomy; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography	2002
Biliary tract FDG uptake secondary to stent placement. Clinical nuclear medicine, 2003, Volume: 28, Issue:4 Topics: Biliary Tract; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cholangitis; Cholestasis, Extrahepatic; Empyema; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Stents; Tomography, Emission-Computed	2003
Value of 18-F-deoxyglucose (FDG) positron emission tomography (PET) for the diagnosis of pancreatic cancer. World journal of surgery, 2003, Volume: 27, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Differentiation of synchronous tumors using FDG positron emission tomography. Clinical nuclear medicine, 2003, Volume: 28, Issue:6 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2003
18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2003, Volume: 7, Issue:8 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed	2003
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology]. Voprosy onkologii, 2003, Volume: 49, Issue:5 Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed	2003
Positron emission tomography with 2-deoxy-2-[(18)F] fluoro- d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion. Journal of gastroenterology, 2003, Volume: 38, Issue:12 Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer. Journal of gastroenterology, 2004, Volume: 39, Issue:1 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:9 Topics: Aged; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique	2004
Role of F18-FDG PET for monitoring of radiochemotherapy -- estimation of detectable number of tumour cells. Onkologie, 2004, Volume: 27, Issue:3 Topics: Cell Count; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2004
F-18 FDG positron emission tomography findings in primary pancreatic lymphoma. Clinical nuclear medicine, 2004, Volume: 29, Issue:9 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2004
[Fluorodeoxiglucose F18 positron emission tomography imaging (F18FDG) for the assessment of rising levels of serum CA 19-9 in pancreatic mucinous cystadenocarcinoma. Report of one case]. Revista medica de Chile, 2004, Volume: 132, Issue:3 Topics: Adult; CA-19-9 Antigen; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms	2004
Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses? Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 2004, Volume: 93, Issue:3 Topics: Adenocarcinoma; Carbon Radioisotopes; Chronic Disease; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Sensitivity and Specificity	2004
F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2005, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed	2005
Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models. Nuclear medicine and biology, 2005, Volume: 32, Issue:2 Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous	2005
Detection of a solid pseudopapillary tumor of the pancreas with F-18 FDG positron emission tomography. Clinical nuclear medicine, 2005, Volume: 30, Issue:3 Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2005
PET: too much of a good thing? Does the plethora of choices impact on patient management? European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:4 Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis	2005
Pancreatic pseudocyst observed on F-18 FDG PET imaging. Clinical nuclear medicine, 2005, Volume: 30, Issue:4 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Squamous Cell; Pancreatic Neoplasms; Pancreatic Pseudocyst; Positron-Emission Tomography; Radiopharmaceuticals	2005
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:7 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2005
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Digestive surgery, 2005, Volume: 22, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR. American journal of roentgenology, 2005, Volume: 185, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity	2005
FDG-PET in the detection of early pancreatic cancer in a BOP hamster model. Nuclear medicine and biology, 2005, Volume: 32, Issue:5 Topics: Animals; Cricetinae; Disease Models, Animal; Fluorodeoxyglucose F18; Male; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Positron-Emission Tomography	2005
Intense PET signal in the degenerative necrosis superimposed on chronic pancreatitis. Pancreas, 2005, Volume: 31, Issue:2 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pancreatitis, Chronic; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity	2005
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Annals of surgery, 2005, Volume: 242, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration. Clinical nuclear medicine, 2005, Volume: 30, Issue:9 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Venous Thrombosis	2005
How useful is integrated PET and CT for the management of pancreatic cancer? Nature clinical practice. Gastroenterology & hepatology, 2006, Volume: 3, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed	2006
18-fluorodeoxyglucose positron emission tomography and pancreatic cancer. Digestive surgery, 2005, Volume: 22, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography	2005
Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. American journal of surgery, 2006, Volume: 191, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Bile Duct Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity	2006
High F-18 fluorodeoxyglucose accumulation in solid pseudo-papillary tumors of the pancreas. Annals of nuclear medicine, 2006, Volume: 20, Issue:6 Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2006
Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis. Journal of affective disorders, 2007, Volume: 99, Issue:1-3 Topics: Adjustment Disorders; Aged; Blood Glucose; Brain; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Limbic System; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prefrontal Cortex; Prognosis	2007
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma. BMC cancer, 2006, Oct-31, Volume: 6 Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Liver Neoplasms; Male; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Treatment Outcome	2006
Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2006, Volume: 6, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Cystadenoma; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies	2006
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:10 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity	2006
The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient. International journal of clinical oncology, 2006, Volume: 11, Issue:6 Topics: Adult; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Hypoglycemia; Insulin-Like Growth Factor II; Male; Neoadjuvant Therapy; Neoplasms, Fibrous Tissue; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2006
Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2007
Positron emission tomography with 2-deoxy-2-[18f] fluoro-D-glucose in the detection of malignancy in intraductal papillary mucinous neoplasms of the pancreas. JOP : Journal of the pancreas, 2007, May-09, Volume: 8, Issue:3 Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2007
A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET. Annals of nuclear medicine, 2007, Volume: 21, Issue:4 Topics: Aged; Autoimmune Diseases; Cell Differentiation; Cholangitis, Sclerosing; Contrast Media; Endoscopy; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Steroids	2007
Positron-emission tomography and computed tomography of cystic pancreatic masses. Clinical radiology, 2007, Volume: 62, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Cyst; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2007
18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Annals of surgery, 2007, Volume: 246, Issue:6 Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2007
[Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:1 Topics: Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed	2008
Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. Journal of gastroenterology, 2008, Volume: 43, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Autoimmune Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals	2008
Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT. Annals of nuclear medicine, 2008, Volume: 22, Issue:2 Topics: Aged; Diabetes Mellitus, Type 2; Fatigue; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9 Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Adult; Aged; Carbon Radioisotopes; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
FDG-PET/CT identifies a curable pancreatic cancer surgical tract metastasis after failure by other imaging modalities. The Israel Medical Association journal : IMAJ, 2008, Volume: 10, Issue:3 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Seeding; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma. Nuclear medicine communications, 1995, Volume: 16, Issue:7 Topics: Adenocarcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Tomography, Emission-Computed	1995
Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. European journal of nuclear medicine, 1995, Volume: 22, Issue:1 Topics: Adenocarcinoma; Blood Glucose; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed; Tomography, X-Ray Computed	1995
Pancreatic tumors: imaging with PET. Radiology, 1995, Volume: 195, Issue:2 Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed	1995
2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology, 1995, Volume: 195, Issue:2 Topics: Adenocarcinoma; Adult; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	1995
Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology, 1995, Volume: 195, Issue:2 Topics: Adenocarcinoma; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	1995
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut, 1995, Volume: 36, Issue:5 Topics: Adult; Aged; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	1995
Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:2 Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1995
F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology, 1994, Volume: 192, Issue:1 Topics: Adenocarcinoma; Cholangiocarcinoma; Contrast Media; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Retroperitoneal Fibrosis; ROC Curve; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	1994
Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results. Nuclear medicine communications, 1993, Volume: 14, Issue:7 Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1993
Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Seminars in nuclear medicine, 1996, Volume: 26, Issue:1 Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	1996
[Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma]. Der Radiologe, 1996, Volume: 36, Issue:5 Topics: Blood Glucose; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed	1996
Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:10 Topics: Colon; Deoxyglucose; Enterocolitis, Pseudomembranous; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radionuclide Imaging	1996
18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer, 1997, Feb-15, Volume: 79, Issue:4 Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Prognosis; Survival Rate; Tomography, Emission-Computed	1997
Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. European journal of nuclear medicine, 1997, Volume: 24, Issue:6 Topics: Adenocarcinoma; Blood Glucose; Chronic Disease; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed	1997
Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:9 Topics: Adult; Aged; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1997
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:9 Topics: Adult; Aged; Blotting, Northern; Chromatography, High Pressure Liquid; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Pancreatitis; Polymerase Chain Reaction; Radiopharmaceuticals; Tomography, Emission-Computed	1997
FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6 Topics: Blood Glucose; Chronic Disease; Diabetes Complications; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed	1998
[Long-term follow-up and therapeutic control of a hepatic metastatic acinar cell carcinoma of the pancreas using FDG PET]. Nuklearmedizin. Nuclear medicine, 1998, Volume: 37, Issue:5 Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Ultrasonography	1998
FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:10 Topics: Adenocarcinoma; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1998
The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease. Surgery, 1998, Volume: 124, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	1998
Diagnosis of pancreatic carcinoma: role of FDG PET. AJR. American journal of roentgenology, 1998, Volume: 171, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	1998
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer. Nuclear medicine communications, 1998, Volume: 19, Issue:11 Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1998
[Can the extent of pancreatic tumors be evaluated reliably enough by positron emission tomography (PET)]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 1998, Volume: 115 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Chronic Disease; Fluorodeoxyglucose F18; Gastrinoma; Humans; Pancreas; Pancreatic Neoplasms; Pancreatitis; Sensitivity and Specificity; Tomography, Emission-Computed	1998
Detection of liver metastases from pancreatic cancer using FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:2 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. The British journal of surgery, 1999, Volume: 86, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Contribution of PET in the detection of liver metastases from pancreatic tumours. Clinical radiology, 1999, Volume: 54, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:11 Topics: Adenocarcinoma; Blood Glucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities. Clinical nuclear medicine, 2000, Volume: 25, Issue:2 Topics: Adenoma, Islet Cell; Adult; Aged; Diagnostic Imaging; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2000
Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas, 2000, Volume: 20, Issue:2 Topics: Area Under Curve; Blood Glucose; Cholangiopancreatography, Endoscopic Retrograde; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Preoperative Care; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
FDG positron emission tomography in pancreatic cancer. Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel, 2000 Topics: Blue Cross Blue Shield Insurance Plans; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration	2000
[Somatostatin receptor scintigraphy (SRS) in a neuroendocrine pancreatic tumor: why SPECT?]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:4 Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography	2000
A combined PET/CT scanner for clinical oncology. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:8 Topics: Adult; Aged; Carcinoma, Squamous Cell; Data Interpretation, Statistical; Duodenal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Polyps; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointestinal endoscopy, 2000, Volume: 52, Issue:3 Topics: Adenocarcinoma; Biopsy, Needle; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations. World journal of surgery, 2000, Volume: 24, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2000
Combined imaging techniques for pancreatic cancer. Lancet (London, England), 2000, Sep-09, Volume: 356, Issue:9233 Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Preoperative diagnosis of pancreatic leiomyosarcoma. International journal of pancreatology : official journal of the International Association of Pancreatology, 2000, Volume: 28, Issue:2 Topics: Actins; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Male; Middle Aged; Muscle, Smooth; Pancreatic Neoplasms; Pancreaticoduodenectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography; Vimentin	2000
Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Cell Division; Cell Nucleus; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed	2001
In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model. Cancer research, 2001, May-15, Volume: 61, Issue:10 Topics: Animals; Cell Division; Disease Models, Animal; Disease Progression; Floxuridine; Fluorodeoxyglucose F18; Genes, p53; Mice; Mice, Transgenic; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; RNA, Messenger; Thymidine Kinase; Thymidylate Synthase; Transforming Growth Factor alpha; Up-Regulation	2001
Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. International journal of oncology, 2001, Volume: 19, Issue:1 Topics: Adenocarcinoma; Aged; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed	2001
Diagnostic usefulness of FDG PET for pancreatic mass lesions. Annals of nuclear medicine, 2001, Volume: 15, Issue:3 Topics: Aged; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positron emission tomography. Annals of nuclear medicine, 2001, Volume: 15, Issue:3 Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Glucagonoma; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Ultrasonography	2001
Physiological FDG uptake in the palatine tonsils. Annals of nuclear medicine, 2001, Volume: 15, Issue:3 Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Palatine Tonsil; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed	2001
Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Annals of surgery, 2001, Volume: 234, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	2002
The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions. Clinical nuclear medicine, 2002, Volume: 27, Issue:3 Topics: Adult; CA-19-9 Antigen; Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2002
Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:2 Topics: Acute Disease; Adult; Aged; Case-Control Studies; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Radionuclide Imaging; Radiopharmaceuticals	2002
[The role of FDG-PET scan in the diagnosis of pancreatic carcinoma]. Orvosi hetilap, 2002, May-26, Volume: 143, Issue:21 Suppl 3 Topics: Adult; CA-19-9 Antigen; Carcinoma; Cholangiopancreatography, Endoscopic Retrograde; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2002
PET with fluorine-18 deoxyglucose for pancreatic disease. Lancet (London, England), 1992, Nov-07, Volume: 340, Issue:8828 Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed	1992